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Physical activity is beneficial for health; physical activity has been linked to reduced risk of 
diseases associated with ageing and reduced risk of mortality. Whereas, oxidative stress is 
seen with ageing and diseases associated with ageing. Taking part in regular physical activity 
leads to adaptive response that enables the body’s antioxidant defence to be better equipped to 
fight against oxidative stress, and indeed exercise training leads to lower level of oxidative 
stress. Exercise intensity seems to be one of key factors that determines the effectiveness of 
exercise. 
This thesis contributes to the existing literature by being the first to investigate the effect of 
exercise on a marker of oxidative stress in the brain, an organ that becomes impaired 
(including oxidative damage) with ageing and diseases associated with ageing. The finding 
from this thesis suggests that brain glutathione (GSH) as measured by magnetic resonance 
spectroscopy (MRS) decreases following an acute bout of exercise in sedentary young men. 
In the periphery, high intensity interval exercise (HII) involving very high intensity intervals 
was found to elicit a greater oxidative stress response in comparison to continuous moderate 
intensity exercise. An unsupervised form of home-based exercise intervention in older adults 
was not successful in increasing physical activity level, which was objectively measured using 
an activity monitor. Thus, as would have been potentially expected, there was no 
improvement in markers of oxidative stress and other health markers in response to the 
exercise intervention.  
The work presented in this thesis used novel approaches, through the application of emerging 
technologies, to study physical activity and its effects.  Brain GSH was altered in response to 
exercise, in an exercise intensity dependent manner, and the brain seems to be protected 
 iii 
against hyperperfusion injury during the high intensity phase of the HII exercise. Observed 
changes in peripheral markers of oxidative stress (GSH, total antioxidant capacity and 
malondialdehyde) were also exercise intensity dependent. Objectively measured physical 
activity levels were not significantly increased by an unsupervised exercise intervention, 
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Oxidative stress is a state that can exist within a cell, tissue or organism, which describes an 
imbalance between oxidants and antioxidants. If the imbalance is severe enough cell damage 
can result. Oxidative stress has been implicated in ageing and with diseases associated with 
ageing, however oxidative stress can be perturbed by lifestyle. Regular exercise leads to many 
health benefits including reducing the risk for diseases, and some of these benefits have been 
associated with reduced oxidative stress. It is now generally accepted that unaccustomed 
exercise can result in oxidative stress, while regular physical activity leads to an adaptive 
response to resist against exercise or non-exercise induced oxidative stress. The level of 
oxidative stress in response to exercise is dependent on many factors, of which exercise 
intensity is one. Blood/plasma and muscle are the most frequently sampled tissues in studies 
that assess exercise induced oxidative stress. No previous human studies have looked at the 
effect of exercise-induced oxidative stress in the brain, an organ that becomes impaired with 
ageing and with diseases associated with ageing. Perhaps one contributing factor to decreased 
health with age is physical inactivity and it is well known that levels of physical activity 
reduce with age. Very few studies use objective measures to assess physical activity in free 
living conditions and most of these studies are cross-sectional in design and thus, there is a 
lack of information on the quality of physical activity in free-living older adults. This thesis 
comprises studies in which methods to monitor oxidative stress in the brain in response to 
exercise in sedentary young adults are developed, and technology to monitor physical activity 




1.2 OXIDATIVE STRESS 
1.2.1 Free radicals and oxidative stress 
Free radicals are molecules with an unpaired electron in their outer orbit. Free radicals, first 
described by Moses Gomberg in 1900 (Gomberg, 1900), initially were not considered to be 
present in living organisms due to their high reactivity and short life span (Lushchak, 2014). 
In 1954, Commoner et al. (1954) provided the first proof that free radicals exist in living 
organisms. Following this, it was assumed that free radicals played deleterious role in 
biological systems, until the 1970s when studies reporting their important role in many 
functions of living organisms started to emerge (Babior et al., 1973, Furchgott and Zawadzki, 
1980). 
Most of the free radicals that are found in living organisms either are, or originate from, 
reactive oxygen species (ROS) or reactive nitrogen species (RNS) (Cooper et al., 2002, 
Fisher-Wellman and Bloomer, 2009). ROS includes oxygen based radicals (such as 
superoxide, hydroxyl, alkoxyl, peroxyl and hydroperoxyl) as well as some derivatives of 
oxygen that do not contain unpaired electrons (such as hydrogen peroxide and lipid 
peroxides). RNS includes nitric oxide and derivatives of nitric oxide such as peroxynitrite. 
ROS and RNS are collectively referred to as reactive oxygen and nitrogen species (RONS). 
The human body produces RONS as by-products of numerous physiological and biochemical 
processes, but primarily as a result of aerobic metabolism (Uttara et al., 2009). Oxygen is 
necessary for the life of aerobic organisms and acts as a terminal oxidant in the mitochondrial 
respiratory chain (Figure 1-1). In the mitochondrial electron transport chain, majority of the 









Figure 1-1Schematic representation of the tetravalent and monovalent reduction of 
molecular oxygen to water.  
Top: The tetravalent reduction of molecular oxygen to water occurs efficiently during 
mitochondrial respiration. Bottom: Alternatively, monovalent reduction can occur which 
produces reactive intermediates such as superoxide anion (O2-•), hydrogen peroxide (H2O2) 
and hydroxyl radical (OH•). 
O2 ® O2-• ® H2O2 ® OH• ® H2O
e e e e
2H+ H+




reduction to water (Comporti et al., 2008). However, a portion of oxygen can be reduced via a 
univalent pathway even under normal conditions, leading to the formation of reactive 
intermediates such as superoxide anion (O2-•), hydrogen peroxide (H2O2) and hydroxyl radical 
(OH•). RONS plays a crucial role in normal functioning, as RONS are involved in many 
functional activities of cells such as control of cell signalling pathways and regulation of gene 
expression (Powers et al., 2011, Uttara et al., 2009).  However, overproduction of free radicals 
can cause oxidative damage to biomolecules which, if severe, can be toxic and may lead to 
cell death. The three main classes of biological macromolecules susceptible to free radical 
attack are lipids, proteins and nucleic acids (Beckman and Ames, 1998). An elaborate system 
of antioxidant defence is in place as a counterbalance to the reactivity of RONS. This finely 
regulated antioxidant system maintains a well-balanced production and elimination of RONS 
resulting in a steady-state RONS level within the cell. Oxidative stress (a concept introduced 
in 1980s (Sies, 1985)) is a state where there is an imbalance between antioxidants and 
oxidants in favour of the oxidants, leading to a disruption of redox signalling and/or 
molecular damage. This imbalance can be an effect of increased RONS production and/or 
depletion of antioxidants including inactivation of antioxidant enzymes.  
Oxidative stress results in a wide spectrum of genetic, metabolic, and cellular responses 
(Davies, 2000). Oxidative stress may modulate gene expression and regulate cell signalling 
pathways, or it may stimulate cell growth or cause a protective temporary growth-arrest of 
cells (Davies, 2000). All of these effects could be regarded as beneficial, or at the very least 
non-detrimental. However, in certain circumstances oxidative stress can cause necrosis or cell 
death. Lushchak (2014) proposed a theoretical classification of oxidative stress according to 
its intensity as basal, low intensity, intermediate intensity and high intensity oxidative stress. 




methods routinely applied. It could be therefore suggested in this case that RONS and 
antioxidants are in balance. At low intensity oxidative stress, there is an adaptive response, 
suggesting RONS are able to overwhelm antioxidants to signal, but are not damaging at this 
level. At intermediate intensity, there is a combined response of adaption vs damage to 
cellular components, whereas, high intensity involves necrosis and apoptosis. This theoretical 
classification bears a striking similarity to the free radical hormesis theory, proposed by  
Radak et al. (2005). This theory is presented in section 1.5.2.1.  
1.3 OXIDATIVE STRESS IN AGEING AND DISEASE 
Ageing can be defined as the progressive accumulation of diverse, deleterious changes with 
time that increase the risk of disease and death (Harman, 2006). One of the most plausible and 
acceptable explanations for the mechanistic basis of ageing is the “free radical theory of 
ageing” which postulates that ageing is the sum of the free radical damage associated with 
suboptimal living condition plus that produced by the inborn ageing process (Harman, 2006). 
Oxidative stress is found to a limited extent in healthy ageing, and to a greater extent in 
diseases associated with ageing such as mild cognitive impairment and dementia (age is the 
greatest risk factor for a number of neurodegenerative diseases) (Mariani et al., 2005). 
Chronic oxidative stress has been suggested to play a primary or secondary role in the 
development of multiple acute and chronic human diseases (Dalle-Donne et al., 2006, Fisher-
Wellman and Bloomer, 2009). Oxidative stress has been implicated in many degenerative 
diseases such as cancer, diabetes and neurodegenerative diseases (Barnham et al., 2004, 
Beckman and Ames, 1998) such as dementia and Alzheimer’s disease. Decline in the 
antioxidant glutathione (GSH) levels and GSH metabolism has been linked to diseases 




1.3.1 Neurodegenerative disease and oxidative stress 
Several neurodegenerative diseases are associated with oxidative stress, and oxidative stress is 
thought to play an important role in the pathogenesis of neurodegenerative diseases such as 
Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, Huntington’s disease 
and multiple sclerosis (Butterfield et al., 2002). Alterations in glutathione homeostasis and 
glutathione-dependent enzymes have been implicated in the induction and progression of 
neurodegenerative diseases including Alzheimer’s disease and Parkinson’s disease (Johnson 
et al., 2012). There is a large amount of compelling data demonstrating increased oxidative 
stress in Alzheimer’s disease (the most common form of dementia) (Nunomura et al., 2001, 
Zhu et al., 2007, Bennett et al., 2009, Bonda et al., 2010, Sultana and Butterfield, 2010), with 
oxidative stress seen early in the disease (Nunomura et al., 2001). In fact, an increased level 
of oxidative stress is also seen in individuals with mild cognitive impairments, a clinical 
population who are at the highest risk to progress to Alzheimer’s disease (Pratico et al., 2002, 
Sultana and Butterfield, 2010). Increased oxidative stress is an early event in AD, with studies 
showing that oxidative stress is detected prior to Aβ deposition and NFT Increased oxidative 
stress and decreased antioxidant capacity has been reported in AD patients compared to age 
matched controls (Aldred et al., 2010, Montine et al., 2002), whereas increased antioxidant 
levels have been linked to reduced risk of Alzheimer’s disease (Mangialasche et al., 2010). 
Brain impairments occur in neurodegenerative diseases associated with ageing such as 
dementia (Alzheimer’s disease (most common form), Parkinson’s disease). Indeed, similarly 
to the periphery (Lang et al., 1992, Puertas et al., 2012), lower GSH levels have been reported 
in the brain in these conditions (Gu et al., 1998, Mandal et al., 2012, Sofic et al., 1992) as well 




1.4 ASSESSMENT OF OXDIATIVE STRESS 
Studies generally report the presence of oxidative stress when one or more (ideally several) 
parameters reflecting disturbance in the redox balance are observed. Commonly used markers 
of oxidative stress include oxidatively modified lipids, proteins and nucleic acids and the level 
and/or activities of antioxidants such as GSH, superoxide dismutase (SOD) and glutathione 
peroxidase (GPx) (Lushchak, 2014). Using the activities of antioxidant enzymes as markers of 
oxidative stress is challenging due to the complexity of their response– depending on the 
intensity of oxidative stress, the activities of antioxidant enzymes may increase, decrease or 
remain unchanged. In accordance with the theory suggested by Luschak and others 
(Lushchak, 2014, Radak et al., 2005) enzymes are usually up-regulated at low RONS 
concentrations as an adaptive response and are decreased at higher RONS concentrations as 
they become depleted. An increase in RONS production on its own is also not a definitive 
marker of oxidative stress as an increase in RONS production does not necessarily define a 
pro-oxidant condition (Powers and Jackson, 2008). Therefore an ideal assessment of oxidative 
stress would include measurement of several oxidatively modified macromolecules along 
with assessment of antioxidant system (Lushchak, 2014). 
1.4.1 Protein Oxidation 
Proteins are major targets for RONS because of their high abundance in biological systems 
and indeed proteins scavenge the majority (50-75%) of produced RONS (Dalle-Donne et al., 
2006). Modification of proteins by RONS leads to the formation of carbonyl groups into 
amino acid side chains. Most protein damage is irreparable and oxidative modification of the 
protein structure can lead to loss of structural function in the affected proteins (Levine and 
Stadtman, 2001). Protein carbonyls are one of the most stable of all of the adducts formed by 




measured by HPLC or ELISA procedures. Other commonly used measures for assessment of 
oxidised proteins include individual oxidised amino acids and nitrotyrosine. 
1.4.2 Lipid Oxidation 
Unsaturated lipids are particularly susceptible to oxidative modification. RONS can attack 
polyunsaturated fatty acids in the cell membrane leading to a chain of chemical reactions 
called lipid peroxidation. The process of lipid peroxidation is initiated by RONS attack on the 
double bond of unsaturated fatty acids which generates highly reactive lipid peroxy radicals 
which leads to a chain reaction of further attacks on other unsaturated fatty acids (Figure 1-2) 
(Barnham et al., 2004, Davies, 2000). Lipid peroxidation leads to the breakdown of lipids and 
the formation of various primary oxidation products such as conjugated dienes and lipid 
hydroperoxides, and secondary oxidation products such as malondialdehyde (MDA) and F2-
isoprostanes. Lipid peroxidation is commonly assessed by measurement of thiobarbituric acid 
reactive substances (TBARS) as a measure of MDA, although this reaction is rather non-
specific for MDA and measures many parameters in addition to lipid peroxidation (Janero, 
1990). MDA can be measured by HPLC, spectrophotometry or spectrofluorescence (Urso and 
Clarkson, 2003). Other frequently used measures of lipid peroxidation includes assessment of 
end products such as isoprostanes, lipid hydroperoxides, conjugated dienes and oxidised low 
density lipoprotein. Assessment of F2-isoprostanes is regarded as one the most reliable 







Figure 1-2 Mechanism of lipid peroxidation. 
Figure adapted from (Gutteridge, 1995). The process of lipid peroxidation is initiated by 
RONS attack on the double bond of unsaturated fatty acids and once the process is initiated, it 
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1.4.3 DNA oxidation 
RONS can cause oxidative damage to both nuclear and mitochondrial DNA. Increased 
oxidation of DNA by RONS, especially by the hydroxyl radical, has been implicated in 
several neurodegenerative diseases (Lovell, Gabbita and Markesbery, 1999, Murata, Ohtsuka 
and Terayama, 2008, Zhang et al., 1999). Hydroxyl radicals can react with DNA in one of two 
ways i) by an addition reaction- where the hydroxyl radical binds to the DNA bases and ii) by 
directly removing a hydrogen atom from DNA resulting in DNA cleavage (Kawanishi, Hiraku 
and Oikawa, 2001, Cooke et al., 2003). Out of the four DNA bases, guanine is the most 
vulnerable to oxidation due to its low oxidation potential (Kawanishi et al., 2001).  Guanine 
oxidation produces 8-hydroxy-2-deoxyguanosine (8-OHdG), which is the most common 
marker used to assess DNA modification (Finaud et al., 2006, Cooke et al., 2006). The 
oxidised nucleotide, 8-OHdG, is excreted via blood and urine (Finaud et al., 2006). Unlike 
oxidatively modified lipids and proteins which may be removed via normal turnover of the 
respective molecules, damage to DNA must be repaired (for example DNA repair by base 
excision repair enzymes) (Evans et al., 2004). Methods for the assessment of oxidative 
damage of DNA include HPLC, mass spectrometric methods and comet assay in urine and 
blood samples (Cooke et al., 2006). 
1.4.4 Antioxidant defences 
Human beings have developed a highly complex system of antioxidant defence, which work 
synergistically and in combination with each other, to protect biomolecules against damage 
from RONS. The antioxidant system includes endogenous (enzymatic and non-enzymatic) 
antioxidants such as GSH, SOD, GPx and catalase (CAT), as well as exogenous antioxidants 
(the diet being the main source) such as vitamin C, vitamin E, carotenoids and polyphenols. 




glutathione (GSH), vitamin C and vitamin E. The endogenous and exogenous antioxidants act 
interactively to maintain redox balance. 
1.4.4.1 Glutathione 
GSH, the most abundant antioxidant in the body, is a ubiquitous molecule present in almost 
all mammalian tissues, and is produced in all organs (the highest being in the liver). Its 
intracellular concentrations usually range from 1 to 10 mM and extracellular concentrations 
(such as in plasma) range from 2-20 µM (Giustarini et al., 2013). Apart from its role in 
antioxidant defences, GSH is involved in a multitude of cellular functions such as protein 
synthesis.  
Figure 1-3 shows GSH redox cycle. GSH provides a first line of defence against ROS- it can 
scavenge free radicals and reduce hydrogen peroxide (H2O2). GSH reduces H2O2 using the 
enzyme GPx, during which GSH itself is oxidised to glutathione disulfide (GSSG). 
Glutathione reductase (GR) reduces GSSG back to GSH using an electron from NADPH. In 
order to maintain a constant intracellular GSH concentration, consumed GSH has to be 
replaced by resynthesis from its constituent amino acids. 
Despite the substantial interest in the measurement of GSH and GSSG in blood, there is 
currently no ‘gold standard’ protocol for sample preparation and analysis in biological 
samples (Giustarini et al., 2013). In blood, GSH should be ideally measured in whole blood as 
GSH is mostly present inside the cell, and thus the concentration of GSH in plasma samples is 







Figure 1-3 Glutathione redox cycle 
Superoxide (O2-•) is converted into hydrogen peroxide (H2O2) by the action of superoxide 
dismutase (SOD). H2O2 is reduced to water (H2O) catalysed by glutathione peroxidase (GPx), 
while glutathione (GSH) is oxidised to glutathione disulfide (GSSG). Gluathione reductase 







(Tietze, 1969), fluorometric and bioluminometric assays. One of the main concerns during 
sample manipulation is the auto-oxidation of thiols which may lead to overestimation of 
disulphides (i.e. GSH or GSSG). To prevent this, various agents such as N-ethylmaleimide 
(NEM) and 2-vinyl pyridine are used to block thiol groups. Only methods such as NMR are 
suitable for measuring GSH in intact cells or non-deprotenised samples. Nuclear magnetic 
resonance spectroscopy (MRS) is the only method that allows non-invasive in vivo 
assessment of GSH. The detection of GSH using MRS in the human brain in vivo was first 
described by Trabesinger et al. (1999) and this technique will be introduced in more detail in 
chapter 3 of this thesis. 
1.4.4.2 Total antioxidant capacity 
Total antioxidant capacity can be used as an indicator of oxidative stress. Methods to assess 
antioxidant capacity typically involve a tissue or a blood sample being added to a chemical 
free radical generation system in vitro and then the measurement of the ability of the sample 
to resist oxidative stress (e.g. resistance to lipid peroxidation) (Urso and Clarkson, 2003). 
Total antioxidant capacity assays include Trolox Equivalent Antioxidant Capacity (TEAC), 
Total Antioxidant Status (TAS), and Ferric Reducing Ability of Plasma (FRAP). 
1.4.4.3 Antioxidant enzymes 
Assessment of antioxidant enzyme activity is also used as a marker of oxidative stress; the 
most commonly enzymes assessed being SOD, GPx, GR and catalase.  Ideally, assessment of 
antioxidant enzyme activity should be carried out in cell samples, as they are active inside the 
cell. 
1.4.5 Measurement of free radicals 
The methods, in order to assess oxidative stress, mentioned so far in this section 1.4 are all 




radicals directly is difficult, primarily due to their short lifetime. Additionally, they are highly 
reactive and occur at low concentrations in living systems. A further limitation is that the 
probes or spin traps that are used to measure free radicals may perturb the biological system 
being investigated (Powers and Jackson, 2008). The most commonly used method to directly 
assess free radical production is electron spin resonance. Other less common methods include 
radiolysis and laser flashphotolysis. 
1.5 CHANGES IN OXIDATIVE STRESS MARKERS IN RESPONSE TO 
EXERCISE 
1.5.1 Overview 
Dillard et al. (1978), in 1978, were the first to report that exercise can result in increased lipid 
peroxidation in humans, and a study by Davies et al. (1982) in rats provided the first evidence 
that skeletal muscle produces RONS and exercise can induce tissue damage as measured by 
marker of lipid peroxidation. Since then, an accumulating body of evidence supports the 
hypothesis that physical exercise has the potential to increase RONS production which can 
result in oxidative stress (Fisher-Wellman and Bloomer, 2009). In response to intense 
exercise, the body’s antioxidant system may not be able to effectively remove the excess 
RONS produced (Kerksick and Willoughby, 2005). A single bout of exercise, dependent on 
factors including exercise intensity and duration, and fitness of the individual, will increase 
RONS production and stimulate adaptive changes, which if repeated via regular bouts of 
exercise can lead to decreased markers of oxidative damage and increased antioxidant 
capacity, both at rest and in response to physical activity (Camiletti-Moiron et al., 2013, 
Finaud et al., 2006, Radak et al., 2008, Radak et al., 2001a). Studies that investigate oxidative 
stress in response to exercise in humans have mostly assessed oxidative stress markers in 




1.5.2 Oxidative stress markers in response to acute exercise 
A single bout of unaccustomed exercise can elicit a transient increase in markers of oxidative 
stress, dependent on factors such as exercise intensity, exercise duration and participant’s 
characteristics (Fisher-Wellman and Bloomer, 2009). Various studies in sedentary humans 
have shown that an acute bout of exercise can change markers of oxidative stress including 
protein carbonyls and lipid hydroperoxides in blood/plasma (Bloomer et al., 2007, Michailidis 
et al., 2007, Steinberg et al., 2007, Wadley et al., 2016a). 
Studies in humans have shown an acute bout of exercise can temporarily decrease GSH in 
blood immediately post exercise which then returns back to baseline level (Elokda et al., 
2010, Elokda et al., 2005, Laaksonen et al., 1999, Steinberg et al., 2007). Elokda et al. (2005) 
found that blood GSH decreased immediately after acute exercise in sedentary participants 
which then returned back to baseline level. Acute exercise has also shown to decrease GSH 
post-exercise in older adults as well as older adults with Parkinson’s disease (Elokda et al., 
2010). To assess exercise-induced oxidative stress by measuring antioxidant response on its 
own is challenging because exercise can result in decrease in antioxidants but the influx of 
antioxidants from secondary sources elsewhere in the body can result in transient increase. 
(Cooper et al., 2002). Changes in antioxidant levels could mean impaired antioxidant 
defences, but they do not necessarily indicate tissue damage (Cooper et al., 2002). 
Exercise mode, intensity, and duration as well as participant’s training status, age, dietary 
intake and gender, all can impact the extent of exercise-induced oxidative stress (Cooper et 
al., 2002, Fisher-Wellman and Bloomer, 2009). The differences across studies in the detected 
markers of oxidative stress in response to exercise therefore could be due these factors such as 
the type of exercise and the training status of the participants. Indeed, accumulating evidence 




and thus the magnitude of oxidative stress in response to a single bout of exercise (Bailey et 
al., 2004, Goto et al., 2007, Lamprecht et al., 2008, Lovlin et al., 1987, Quindry et al., 2003, 
Wang and Huang, 2005). For instance, in a study of sedentary men assessing the response of 
acute bout of moderate or high intensity exercise (of the same duration) in blood lymphocytes 
reported greater decreases and increases in GSH level and lipid peroxidation respectively in 
response to high intensity exercise compared to moderate exercise (Wang and Huang, 2005). 
One form of exercise that involves high exercise intensity is high intensity interval exercise 
(HII), which is gathering considerable interest as an alternative exercise method to improve 
health. One of the reasons for the emerging interest in this time-efficient form of exercise is to 
counter the reported perceived “lack of time” associated with traditional exercise guidelines 
(Gibala et al., 2012). There are various forms of HII, but generally it is comprised of repeated 
bouts of brief intermittent exercise of high intensity of ~85% to 95% or beyond maximal 
aerobic capacity (Lucas et al., 2015). Emerging evidence suggests that, compared to the 
traditional continuous moderate-intensity exercise, HII provides equivalent if not superior 
benefits for metabolic, cardiac and vascular adaptations (Lucas et al., 2015). A study carried 
previously in our lab, found that HII elicited oxidative stress response similar to those by  
both high-intensity and moderate-intensity exercise (Wadley et al., 2016a). This thesis 
examined HII further, by using a higher volume HII compared to the low volume HII used by 
Wadley et al. (2016a). 
Timing of sampling should also be considered, as an increase in oxidative stress markers in 
blood and skeletal muscle may persist for and/or appear several days after exercise 
(Michailidis et al., 2007, Nikolaidis et al., 2008, Vollaard et al., 2005). Other factors that 
could impact the observed oxidative stress include the sensitivity and specificity of the 




Wellman and Bloomer, 2009), however the finding by Veskoukis et al. (2009) (in an animal 
model) suggests that markers of oxidative stress in blood, skeletal muscle, heart and liver are 
correlated. Nevertheless, markers of oxidative stress, as assessed by increased damage to 
lipids and proteins along with changes in antioxidant systems, in response to exercise have 
been well documented (Cooper et al., 2002).  
1.5.2.1 Hormesis 
The hormesis hypothesis suggests that biological systems respond positively to chemicals, 
toxins and radiation until a threshold is reached, whereby the system breaks down. Radak et 
al. (2005) extended the hormesis theory to the free radical generating effects of exercise, 
encompassing a low-dose stimulation or beneficial effect through to a high-dose inhibitory or 
toxic effect.  The hormesis theory applied to exercise encompassing a bell shaped curve is 
shown in Figure 1-4. Production of RONS above the optimal threshold (which is currently an 
undefined level) may serve to overwhelm antioxidant defences, and thus may result in 
extensive oxidative damage (Fisher-Wellman and Bloomer, 2009). 
1.5.3 Possible mechanisms of RONS production during exercise 
There are numerous potential sites at cellular level and mechanism for RONS production in 
response to exercise include mitochondria, NADPH (nicotinamide adenine dinucleotide 
phosphate) oxidase, PLA2 (phospholipase A2)-dependent processes, and xanthine oxidase (as 
shown in Figure 1-5); although at present the precise role of each of these in exercise induced 
RONS production remains unclear (Powers and Jackson, 2008, Powers et al., 2011, Vollaard 
et al., 2005). Primary ROS generation in response to acute exercise can occur via 
mitochondrial respiration, and oxidase enzymatic activity (such as NADPH oxidase and 










Figure 1-4 Hormesis theory to free radical generating effect of exercise 
The theoretical model which extends the hormesis theory to the RONS generating effects of 
exercise, encompassing a bell shaped curve with a low-dose stimulation or beneficial effect 









Mitochondria are considered the main source of RONS during normal respiration. During 
aerobic respiration in the mitochondria (in order to produce energy in the form of ATP), 
oxygen (O2) is reduced to water (H2O). However, it seems that mitochondria electron 
transport is not perfect, and one-electron reduction of O2 to O2-• occurs (Beckman and Ames, 
1998). Next, the dismutation of O2-• (both spontaneous and catalysed by SOD) yields H2O2, 
which subsequently may form hydroxyl radicals and other low-molecular weight oxidants 
located in the RONS cascade. It is a common assumption that increased mitochondrial oxygen 
consumption in response to exercise leads to increased RONS production; superoxide 
production in the mitochondria has been generally cited as the predominant source of RONS 
during exercise (Cooper et al., 2002, Di Meo and Venditti, 2001, Powers and Jackson, 2008, 
Vollaard et al., 2005). However, studies suggest that mitochondria may not be the dominant 
source of exercise-induced RONS production; for instance mitochondria produce more RONS 
in basal respiration compared to active respiration (Powers et al., 2011, Vollaard et al., 2005).  
NADPH oxidase (located in several cellular compartments including sarcoplasmic reticulum, 
transverse tubules, and sarcolemma) produces superoxide by transferring electrons from 
NADPH to oxygen and is considered to contribute to exercise-induced RONS production 
(Powers et al., 2011). Superoxides have been reported to be released into extracellular spaces 
as the plasma membrane contains redox systems capable of electron transfer across the 
membrane (Powers et al., 2011). Activation of the enzyme PLA2 can activate NADPH 
oxidase, stimulate RONS production in both the mitochondria and the cytosol, and release 









Figure 1-5 Sources of RONS at cellular level 
Figure adapted from (Powers et al., 2011). Schematic diagram depicting the potential sites of 
RONS sources during / following exercise. SR/T-tubule – sarcoplasmic reticulum / transverse 
tubule, PLA2 – phospholipase A2, SOD – superoxide dismutase, GPx – glutathione 
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may also be detected outside of the cell. Xanthine oxidase generates superoxide and  xanthine 
by oxidising hypoxanthine (Powers et al., 2011). It is especially involved in RONS production 
during anaerobic exercise such as at very high intensity exercise (Radak et al., 2013). 
1.5.3.1 Ischaemia-reperfusion 
An alternative mechanism for ROS production in response to exercise involves ischaemia-
reperfusion (Cooper et al., 2002). Intense exercise causes transient tissue hypoxia in several 
organs as blood is directed away to increase blood supply in active skeletal muscles (Cooper 
et al., 2002), and this can result in activation of xanthine oxidase (Sachdev and Davies, 2008). 
Additionally, exercising at intensities above the V̇O2max can lead to hypoxia in muscle fibres 
(Cooper et al., 2002). On cessation of exercise, reperfusion occurs and re-oxygenation of 
these tissues can result in burst of superoxides and H2O2 (Sachdev and Davies, 2008).  
1.5.4 Oxidative stress markers in response to exercise training: Adaptation 
It seems paradoxical that although oxidative stress is linked to ageing and numerous 
pathologies (as discussed in section 1.3) while acute exercise stimulates oxidative stress but 
regular exercise decreases oxidative stress and is linked to numerous health benefits including 
reducing risk of mortality as well as reduced risk of these very pathologies (Powers et al., 
2011). The first study to report that exercise-induced RONS production could be a stimulus 
for exercise training adaptation was in the 1980s by Davies et al. (1982), since which 
numerous studies have accumulated that support this finding (Powers et al., 2011).  RONS 
can activate several different signalling pathways including the mitogen-activated protein 
kinase (MAPK) and nuclear factor κB (NFκB) pathways (Powers and Jackson, 2008). The 
activation of these pathways leads to adaption of cells to oxidative stress through upregulation 
of antioxidant enzymes such as SOD and catalase (Powers and Jackson, 2008). In addition 




GSH and GSH:GSSG ratio. This upregulation in the body’s antioxidant defence system 
(Douris et al., 2009, Elokda and Nielsen, 2007, Fatouros et al., 2004), increases protection 
against oxidative stress during subsequent exercise training (Fatouros et al., 2004, Fisher-
Wellman and Bloomer, 2009).  
1.5.5 Exercise-induced oxidative stress: assessment in the brain 
As discussed in section 1.3, oxidative stress has been implicated in ageing and 
neurodegenerative diseases such as Alzheimer’s disease, and Parkinson’s disease where the 
brain is the organ most affected by the disease. The brain is highly susceptible to oxidative 
stress and indeed the presence of oxidative stress in the brain has been demonstrated in these 
conditions. As exercise can act favourably to reduce oxidative stress, there is a need to 
investigate the effect of exercise on oxidative stress is the brain. However, to date, no study 
has investigated the effect of exercise on oxidative stress markers in the human brain. The 
underlying theme of the first two experimental chapters of this thesis was to assess 
antioxidant response in the brain. 
1.5.6 Habitual physical activity 
Physical activity is defined as any bodily movement produced by skeletal muscles that 
requires energy expenditure, whereas, exercise is a subset of physical activity that is planned, 
structured, and repetitive with the intention to improve or maintain physical fitness 
(Caspersen et al., 1985). Physical activity, whether exercise or non-exercise, positively 
contributes to overall health. Globally, a third of adults do not reach the recommended levels 
of physical activity- those in high income countries are more inactive, and also older adults 
are less active to younger adults (Hallal et al., 2012). Physical inactivity has been reported to 




There is now strong evidence that links regular physical activity or exercise to higher 
cognitive function (Colcombe and Kramer, 2003, Lautenschlager et al., 2008), decreased 
cognitive decline (Sofi et al., 2011) and reduced risk of numerous diseases including the 
diseases associated with ageing such as Alzheimer’s disease (Brown et al., 2013, Hamer and 
Chida, 2009), dementia (Hamer and Chida, 2009, Laurin et al., 2001), cancer (Warburton et 
al., 2006, Wen et al., 2011) and diabetes (Warburton et al., 2006). Physical activity or exercise 
is also linked to reduced mortality (Hupin et al., 2015, Warburton et al., 2006, Wen et al., 
2011). The currently recommended physical activity level for adults is 150 min/week of 
moderate-intensity physical activity or 75 min/week of vigorous-intensity activity (Public 
Health England, 2014). The guidelines by the Public Health England on physical activity for 
older adults are: i) Those who participate in any amount of physical activity gain some health 
benefits. Guidelines go on to clarify that some physical activity is better than none, and more 
physical activity provides greater health benefits. ii) Physical activity should add up to at least 
150 min/week of moderate-intensity activity. iii) Those who are already regularly active at 
moderate-intensity, comparable benefits can be achieved through 75 min/week of vigorous-
intensity activity or a combination of moderate and vigorous activity. iv) Those who are at 
risk of falls should incorporate physical activity to improve balance and coordination on at 
least two days a week (Public Health England, 2014). However, it may be that even a lower 
dose than the recommendation is sufficient for attaining exercise benefits (Hupin et al., 2015, 
Lee et al., 2014, Wen et al., 2011). For example, Wen et al. (2011) found that a low-volume 
physical activity (90 min/week moderate-intensity) had significant health benefits for both 
adults (20-59 years) and older adults (≥60 years). In agreement, Hupin et al. (2015) also 
reported that low-volume physical activity reduced mortality in older adults, a demographic 




physical activity has been shown to be effective also in attenuating oxidative stress in older 
adults. Low volume (100 min/week) exercise training in older adults has also been shown to 
decrease markers of oxidative damage and increased antioxidant defence (Takahashi et al., 
2013).  
1.5.6.1 Objective measure of habitual physical activity 
Recommendations for low-intensity physical activities are missing from the current 
guidelines, and not as much is known about low-intensity physical activities, and whether 
they also have similar benefits to that in the recommended physical activity guidelines (Lee 
and Shiroma, 2014). Studies investigating the effects of habitual physical activity generally 
are limited in the estimation of physical activity by using self-report tools such as 
questionnaires or diaries. Such self-reports have issues of subjectivity and recall bias, and may 
also have problems associated with inaccuracy especially for estimation of housework and 
occupational physical activity (Hallal et al., 2010). Additionally, observational 
epidemiological studies, which also use self-reports, tend to limit their assessments to 
physical activities of moderate and vigorous intensities only, as self-reports are more reliable 
and valid for moderate to vigorous intensity activities compared to low-intensity activities 
(Lee and Shiroma, 2014). Thus current guidelines do not prescribe low-intensity physical 
activity. This is not because there is data to indicate non-benefit, but rather because there are 
very few existing datasets available (Lee and Shiroma, 2014). 
Emerging technologies assessing measurement of body movements is a promising alternative 
objective method for future assessments of habitual physical activity, in particular 
accelerometry. These technologies allow estimation of the frequency, duration, and intensity 
of physical activity in free-living individuals. Additionally accelerometry records physical 




assessments usually prompt the respondent to report activities lasting at least 10 minutes, thus 
the granularity of data is greater (Hallal et al., 2012, Hallal et al., 2010). The most commonly 
used physical activity monitors are pedometers and accelerometers, which can vary in 
sensitivity, cost, memory, and software capabilities. Pedometers are activity monitors which 
measure the number of steps that a person takes during ambulatory activity such as walking or 
running, and are attached by a waistband in the midline of the thigh on either of the leg 
(Berlin et al., 2006). Pedometers cannot identify intensity level as it does not take into account 
the intensity of vertical displacement (Berlin et al., 2006). Pedometers can be very accurate in 
individuals without any mobility impairments, however they can underestimate the steps in 
individuals with reduced mobility or impairments who may have slower gait speed, irregular 
and unsteady gait patterns (Berlin et al., 2006). Accelerometers are activity monitors that 
measure both the quantity and intensity of movement, and are capable of measuring the 
intensity, frequency, pattern, and duration of activity (Berlin et al., 2006). Accelerometers can 
be worn on the waist, wrist, or ankle. Actigraph is the most commonly used accelerometer in 
studies using this kind of technology (Murphy, 2009).  
Although accelerometers provide objective measurements of physical activity, there are some 
limitations. Typical placement position of accelerometers are on the hip, and thus upper body 
movements are not measured (Lee and Shiroma, 2014), especially in those with mobility 
issues. These devices also cannot identify if a person is carrying weight, during which more 
energy is spent. There are several issues to take into account while measuring physical 
activity in older adults that are unique to this population, for instance the type and intensity of 
activities that they engage in are different to younger adults (Murphy, 2009). Currently there 
are studies that have used accelerometry to objectively measure physical activity, however 




activity with various health factors (Ekelund et al., 2009, Gennuso et al., 2013, Healy et al., 
2008, Lee and Shiroma, 2014).  
1.6 OVERVIEW OF THESIS 
The aims of the thesis was to  
1. develop an MRS method to measure GSH in the brain  
2. investigate the effect of exercise on GSH in the brain in sedentary humans 
3. assess oxidative stress in response to different exercise intensities in the context of 
peripheral oxidative stress and cerebral blood flow 
4.  investigate a device capable of objectively measuring habitual physical activity in 
sedentary older adults 
5. assess the effect of low dose exercise (less than the recommended guideline) in older 
adults on markers of oxidative stress and other health markers  
The study presented in chapter three details the steps in the method development for 
assessment of GSH in the brain using MRS. Then in chapter four, the effect of exericse on 
brain GSH in young sedentary participants was investigated, using two different types of 
acute exercise bouts that differed in exercise intensity. Other markers of oxidative stress were 
also assessed in the plasma/blood. Cerebral blood flow in response to these two different 
exericse bouts were also assessed. Finally, chapter five looked at the effect of an 
unsupervised exericse intervention in older adults on markers of oxidative stress as well as 
other health markers such as physical fitness. Physical activity was measured objectively 
using a commercially available activity monitor Basis Peak. The appropriatness of this 














Glacial acetic acid, hydrochloric acid and multiwall plates were purchased from Fisher. 2,4-
Dinitrophenylhydrazine was purchased from Camlab chemicals. The antibodies mouse IgE 
anti-dinitrophenyl and rat anti-mouse IgE conjugated horseradish peroxidase were purchased 
from Sigma and AbD Serotec respectively. All other chemicals and reagents were purchased 
from Sigma. 
2.2 CHEMICAL ASSAYS 
Absorbance values for all assays were measured using plate reader (Multiskan MS, 
LabSystems, Finland). 
2.2.1 Total antioxidant capacity measurement using FRAP assay 
Plasma total antioxidant capacity was measured using the ferric reducing ability of plasma 
(FRAP) assay as described by Benzie and Strain (1996) (inter and intra-assay coefficient of 
variation (CV) <3 % and <1 % respectively). Working reagent was made by mixing i) 30 ml 
acetate buffer (300 mM) at pH 3.6 (3.1 g C2H3NaO2 in 16ml glacial acetic acid per litre of 
buffer solution), ii) 3 ml TPTZ (10 mM) (2,4,6-tripyridyl-s-triazine) in 40 mM HCl, and iii) 3 
ml FeCl3.6H2O solution (20 mM). Samples (1:1 dilution) and standards (10 µl) were added to 
the respective wells of a multiwell plate, followed by addition of working reagent ( 300 µl).  
After incubating the sample and reagent mix for 8 minutes at room temperature, the 
absorbance values were measured at 650 nm. Standard curve of known concentrations of 
commercially available ascorbic acid (0-1,000 µM) was used to estimate the antioxidant 
power of the samples. The antioxidant power as measured by FRAP is double that of an 




double that of Fe (II) (Benzie and Strain, 1999). Mean intra-assay coefficient of variation 
(CV) was 5 %.   
2.2.2 Lipid peroxidation measurement using MDA assay 
Lipid peroxidation was measured in plasma samples using the malondialdehyde (MDA) 
assay. The basis of the method is the reaction of MDA with thiobarbituric acid (TBA) at low 
pH and high temperature (90-100 °C) to form a coloured complex, the MDA-TBA adduct, 
with maximal absorption at 532nm. 
In brief, 100 µl samples were mixed with 100 µl trichloroacetic acid (410 mM in 33.3 mM 
H2SO4) and 800 µl the colour reagent (4.6 mM thiobarbituric acid, 1.74 M glacial acetic acid, 
and 0.67 µM butylated hydroxytoluene). After boiling vigorously in boiling water (100 °C) 
for one hour, the reaction was stopped by placing in ice bath for 10 minutes. Supernatant was 
read at 540 nm in multiwell plate. Standard curve of known concentrations of commercially 
available 1,1,3,3-tetramethoxypropane was used to estimate MDA levels in the samples. 
2.2.3 Measurement of protein content using BCA method: 
Plasma protein concentration was assessed using bicinchoninic acid (BCA) assay which is 
based on the method described by Smith et al. (1985). Standards (0 to 1 mg/ml) were prepared 
by diluting bovine serum albumin (BSA). Fresh working solution was prepared by mixing 
BCA solution (Sigma) with copper sulphate solution (4% w/v) in a 50:1 ratio. Samples (1:200 
dilution) and standards (10 µl) were added to the respective wells in a multiwell plate. 
Working solution (200 µl) was added to each well. Following incubation at room temperature 





2.2.4 Protein oxidation measurement using ELISA method 
Protein carbonyl concentration was measured in plasma samples using the enzyme-linked 
immunosorbent assay (ELISA) method that uses anti-dinitrophenyl (DNP) antibody for 
measuring total protein carbonyl groups, first described by Buss et al. (1997) which was 
further developed by Carty et al. (2000) (inter and intra-assay CV 5 % and 1 % respectively).  
Standard preparation: 
Standards for the assay were prepared by the method described by Buss et al. (1997). In brief, 
the standards were prepared by mixing varying proportions (0-100 %) of oxidised BSA (using 
2,2'-azobis (2-amidinopropane) dihydrochloride (AAPH)) with fully reduced BSA (using 
sodium borohydride) to produce standards of a range of carbonyl values. Carbonyl content 
was determined as nmol/mg protein using the molar absorption coefficient (e360 = 22,000 M-1 
cm-1). Carbonyl values are expressed as nmol/mg protein. Standards were aliquoted and 
stored at -70 °C. 
ELISA method: 
Samples (diluted in coating buffer (50 mM sodium carbonate at pH 9.2) and standards (50 µl) 
were allowed to bind to the respective wells of multi-sorb plates (Nunc, Fisher Thermo 
Scientific) for 1 hour at room temperature. After washing (3x each wash) the plates with TBS 
wash buffer (6 g/L Tris HCl and 9 g/L NaCl with 0.05 % Tween-20), 2,4-
dinitrophenylhydrazine (DNPH) (1 mM in 2 M HCl) was added and the plates were incubated 
for another 1 hour. Following another wash, the plates were incubated overnight at 4 °C with 
TBS with 0.1 % Tween-20 (200 µl) to block any non-specific binding. Primary antibody 
(mouse IgE anti-dinitrophenyl, 50 µl, 1:1000 dilution) was added following a wash with wash 




incubated for 1 hour with  secondary antibody (anti-mouse IgE horse radish peroxidase 
conjugate, 50 µl, 1:5000 dilution) at room temperature. The plates were washed, to remove 
any excess unbound antibodies. Then, 50 µl substrate (10ml citrate phosphate buffer (citric 
acid and disodium hydrogen phosphate, 0.5 M at pH 5) containing 8 µl H2O2 and 2 mg o-
phenyldiamine tablet) was added. After, 1 hour incubation in the dark at room temperature, 
the reaction was stopped with 2 M sulphuric acid and absorbance values were measured at 
490 nm. Mean intra-assay CV was 13%. 
2.2.5 Brain derived neurotropic factor 
Plasma brain derived neurotropic factor (BDNF) was measured using a sandwich ELISA 
method with a commercially available kit (BDNF Quantikine ELISA kit, R&D systems, 
Minneapolis, USA) according to the manufacturer’s instructions (inter and intra-assay CV 9 
% and 5 % respectively). In brief standards and samples (1:1 dilution, 50 µl with 100 µl 
diluent) were added into the respective wells of the provided multiwell plate which is pre-
coated with monoclonal antibody specific for human BDNF. During incubation the BDNF in 
the samples were allowed to bind to the antibody. Next, enzyme-linked antibody that is 
specific for BDNF was added. After a wash to removed unbound antibody, a substrate 
solution was added for colour development. A stop solution was added and the absorbance 
was read at 450 nm. Mean intra-assay CV was 8%. 
2.3 CEREBRAL BLOOD FLOW MEASUREMENT  
Blood flow velocity of the middle cerebral artery (MCAv) was measured with a 2-MHz pulse 
wave transcranial Doppler (TCD) ultrasound system (Compumedics Ltd, Germany). TCD is a 
non-invasive method that allows beat-to-beat measure of changes in blood flow velocity thus 




on the detection of frequency shifts from insonated red blood cells. The middle cerebral artery 
was insoated via the temporal window above the zygomatic arch of the head. After a 
satisfactory signal was found, the probe was fixed in place with a headband. MCAv was 
acquired continuously using an analog-to-digital converter (Powerlab; ADInstruments) 
interfaced with a computer, and were subsequently analysed using commercially available 









3 Chapter 3: Development of an MRS method to assess brain 





Magnetic resonance spectroscopy (MRS) provides a non-invasive technique to measure brain 
metabolites. Glutathione (GSH) is one of the most abundant antioxidants in the human body, 
however detection of GSH in the brain using MRS is challenging due to spectral overlap and 
the comparatively small concentration of GSH compared to other metabolites. Using the 
MEGA-PRESS technique, a method for GSH detection in the brain (anterior cingulate cortex) 
was optimised by conducting experiments both in vitro and in vivo. Oxidation of GSH 
phantoms confirmed the identity of reduced GSH, and suggested that oxidised GSH (GSSG) 
did not contribute to the detected GSH signal. Quantification was undertaken using the freely 
available software jMRUI. Repeated scanning showed reproducibility of the GSH signal over 




3.2 INTRODUCTION  
MRS is an emerging method to assess brain GSH. MRS provides biochemical information 
non-invasively, which becomes particularly useful if the region being investigated is difficult 
to access such as the brain. 
The phenomenon of nuclear magnetic resonance occurs when an atomic nucleus with a 
magnetic moment (or spin) is placed in a magnetic field (B) can exhibit resonance behaviour. 
This magnetic resonance (MR) effect is governed by the Larmor equation  
w = -γB 
where, w is the resultant resonance frequency, and γ is gyromagnetic ratio which is a nucleus 
specific constant. 
Nuclei such as 1H, 13C and 31P possess a magnetic moment which can be thought of as 
microscopic magnets. When placed in a magnetic field the spins become polarised, and are 
either parallel or antiparallel, longitudinal to the external magnetic field. The spins that are 
polarised parallel to the field are in a lower energy state, which is the preferred state.  
In MRS, the region being assessed is placed in an external magnetic field. Then in order to 
detect signal, a radio frequency pulse (RF) (an electromagnetic wave) is applied (Stagg and 
Rothman, 2014), shown in Figure 3-1. The RF pulse has two effects on the protons (that 
occurs simultaneously and independently): i) it transits the protons to a higher level of energy 
(i.e. antiparallel) leading to decrease of longitudinal magnetisation and ii) it generates a new 
magnetisation in the transverse direction called transverse magnetisation (Schild, 1990). Then 









Figure 3-1 Magnetisation by the RF pulse 
Right image: Magnetic field of protons longitudinal to the external magnetic field 
(longitudinal magnetisation- big yellow arrow) Left image: RF pulse is applied which causes 
i) decrease in longitudinal magnetisation (yellow arrow) and ii) Generation of a new 








the initial state. The longitudinal magnetisation increases again (longitudinal relaxation), 
described by time constant T1. The transverse magnetisation starts to disappear, a process 
called transversal relaxation (described by the time constant T2). During relaxation, signal is 
emitted– this free-induction decay (FID) response signal is detected by the scanner 
(Tognarelli et al., 2015). As MRS signal (a spectrum) is heavily influenced by 
electromagnetic noise, a number of spectra are obtained which are then averaged/added up in 
order to improve the signal quality (i.e. to improve signal to noise ratio) (Alger, 2010). 
As water is the most prevalent hydrogen (1H) containing compound in the human tissue, it 
contributes the largest part of the 1H MR signal (Hutton et al., 2009). When a human is placed 
in the scanner, all of the body’s nuclei of the same atom, say 1H, do not exhibit the same 
resonance frequency, thus causing frequency shifts. This is because minute variations occur 
depending on the molecule that the atom is embedded in. These variations are based on two 
different effects: chemical shift and J-coupling, both rely on the molecules’ chemical and 
geometric composition (Stagg and Rothman, 2014). Chemical shift is the result of the 
chemical environment around the atomic nucleus at hand. J-coupling refers to an interaction 
between non-identical nuclear spins within a molecule through the electrons of covalent 
bonds. These variations allow the discrimination of nuclei that belong to different molecular 
configuration. 
Trabesinger et al. (1999) were the first to detect GSH in vivo in the human brain by MRS. 
This is the only method which allows non-invasive measurement of GSH (Mueller et al., 
2001). It has been challenging to reliably measure GSH with MRS for two main reasons: i) 
the concentration of GSH is inherently low compared to other brain metabolites, and ii) GSH 
peak has spectral overlap with other neurotransmitters which are present in much greater 




the Cr peak. Apart from spectral overlap, problems of measuring brain GSH include 
complicated spectral patterns resulting from strong coupling between some of its hydrogen 
nuclei.  Nevertheless, Holmay et al. (2013) showed that MRS is a method that is capable of 
detecting changes in GSH levels in the human brain; in this study the participants were given 
GSH precursor N-acetylcysteine intravenously. However, no previous studies have assessed 
whether MRS is sensitive enough to detect potential changes in GSH following a 
physiological stimulus such as exercise.  
3.3 METHODS 
3.3.1 MRS GSH 
GSH is a tripeptide (L-γ-glutamyl-L-cysteinyl-glycine), and each peptide residue gives rise to 
a signal of particular resonance. The cysteinyl residue is most suitable for use in the detection 
of GSH using MRS, as the resonances of the glutamyl and glycine compounds are heavily 
overlapped by other metabolites. The cysteine β-CH2 of GSH resonates at 2.95 ppm- other 
brain metabolites that resonate nearby include Cr (3.03 ppm), aspartate (2.82 ppm), GABA 
(3.01 ppm), and macromolecules (2.98 ppm) (Terpstra et al., 2003). 
All vivo and vitro scans were undertaken using 1H-MRS with a Philips 3.0 T Achieva scanner 
using MEGA-PRESS, as described below.  
3.3.2 MEGA-PRESS 
MEGA-PRESS (MEshcher-Garwood Point RESolved Spectroscopy) is a difference-edited 
MRS technique that allows separation of GSH signal from the overlapping signals from other 
metabolites. MEGA-PRESS utilises known couplings within the GSH molecule by editing the 
cysteinyl β-CH2 protons of GSH resonating at 2.95 ppm, which are J-coupled to the cysteinyl 




selectively refocus the evolution of J-coupling to the GSH spins. Two alternate datasets that 
differed in the treatment of the GSH spin systems were collected– signal for each type of 
treatment were collected in alternate order, one after the other. Signals for the different 
treatments were collected in such alternate fashion in order to minimise the effect arising from 
hardware instabilities or any subject movements. Signals collected with the application of the 
editing pulse is referred to as edit-on signals. Signals collected with the pulse applied 
elsewhere (thus allowing the J-coupling to evolve freely) is referred to as edit-off signals. 
In order to measure GSH signal, during post-processing the edit-on signals were subtracted 
from the edit-off signals– this removed all the peaks leaving behind only those that were 
affected by the editing pulse (most of the peaks were not affected by the editing pulse). 
Unsuppressed water signal was acquired as a separate scan after the GSH scan– this water 
signal was used as tissue water for concentration reference of metabolites. 
3.3.3 In vitro GSH measurement and assessment of potential GSSG contribution 
Standards, or so called phantoms, were used to confirm the spectral pattern of GSH, and also 
to refine an optimal sequence using a MEGA-PRESS sequence. GSH (Sigma-Aldrich, 
G4251) solutions were prepared in a physiologically representative pH (pH 7.2) phosphate 
buffer condition. GSH phantoms (GSH concentration ranging from 14 to 70 mM) were made 
and also included other metabolites found in the brain– sodium azide (15 mM), sodium 
chloride (800 mM), sodium formate (200 mM), GABA (3 mM), N-Acetyl-L-aspartic acid (25 
mM), Cr (20 mM), choline (Ch) (6 mM), myo-inositol (15 mM), glutamate (25 mM), 
glutamin (12 mM), lactate (10 mM), 3-(Trimethylsilyl)-1-propanesulfonic acid sodium salt (2 
mM), potassium phosphate monobasic (28 mM), and potassium phosphate dibasic (72 mM) at 




To assess the GSSG signal and potential overlap with the GSH signal in the MRS spectrum, 
an oxidised GSH phantom was made (GSH (30 mM), sodium formate (200 mM), potassium 
phosphate monobasic (30 mM), and potassium phosphate dibasic (70 mM) at pH 7.2) and was 
oxidised by the addition of hydrogen peroxide (H2O2) (30 mM). Scans were acquired before 
and after oxidation with H2O2. 
Phantoms were stored and scanned in 250 mls short necked round bottom flasks. For 
scanning, the volume of interest (VOI) (30×30×20 mm) was placed at the centre of the flask. 
As the MRS signal can be influenced by pH and temperature, phantoms were stored at - 4 °C 
and were allowed to rest at room temperature before being scanned. Additionally, phantom 
solutions degrade over time, especially GSH, therefore various phantoms were made over the 
course of this method development study. Wherever possible, all scans assessing a particular 
phantom concentration or a scan parameter were scanned in one session.  
3.3.4 Quantification of GSH using jMRUI 
All of the MRS data were analysed by the author using the freely available software jMRUI 
(which uses java-based graphical user interface to analyse the time-domain MRS data). 
Spectral peaks and patterns provide a direct measure for the concentration of the metabolites, 
as the corresponding area of spectral peak is directly proportional to the number of nuclei that 
contribute to it and to the abundance of the resonating nucleus (Jansen et al., 2006, Stagg and 
Rothman, 2014).  Data were exported from the scanner as *.SDAT and *.SPAR files and 
opened in jMRUI as a time series. The edit-on and edit-off spectra were 180° out of phase. 
Chemical shifts were reported with reference to sodium formate singlet resonance at 8.4 ppm 
for the phantom data and to NAA singlet resonance at 2.01 ppm for the brain data. The water 




Decomposition) filter. GSH was quantified by peak fitting using an algorithm called the 
advanced method for accurate, robust, and efficient spectral fitting (AMARES), after 
selecting the GSH region using an ER filter. In phantoms, GSH concentrations were estimated 
using tissue water as internal standard. For the brain data, GSH concentrations were estimated 
using tissue water as concentration standard as described by Gasparovic et al. (2006). The 
observed water signal in MRS comes from a combination of the grey matter (GM), white 
matter (WM), and cerebrospinal fluid (CSF) water fractions, and each of these are weighted 
by different relaxation times (Gasparovic et al., 2006). It is necessary to modify the internal 
water concentration on the basis of the GM, WM and CSF content of the volume assessed, 
and the MRS water content of the grey and white matter fractions (Keevil et al., 1998). 
The T1-weighted images were segmented using SPM8 (Wellcome Trust Centre for 
Neuroimaging, University College London, UK) to determine the percentage of GM, WM and 
CSF in each VOI. The concentration of GSH was calculated as follows, 
Corrected GSH concentration (mM/kg brain tissue) = (fGM * RH2O_GM + fWM * RH2O_WM + fCSF 
* RH2O_CSF) * (SGSH_obs /SH20_obs) * [1/(1- fCSF)] * (1/ RGSH) * [H2O] * (#HH2O / #HGSH) * 1000 
           Equation 1 
where, 
SGSH_obs is observed GSH signal, SH20_obs is observed water signal, [H2O] is molal 
concentration of MR visible water in metabolite solution of the parenchyma (= 55.51), #HGSH 
is the number of proton that give rise to GSH peak (= 2), and #HH2O is the number of proton 
water protons (= 2). 




RH2O_GM = exp[-TE/T2H20_GM]* [1 – exp (-TR/T1H2O_GM)]     Equation 2 
RH2O_WM = exp[-TE/T2H20_WM]* [1 – exp (-TR/T1H2O_WM)]    Equation 3 
RH2O_CSF = exp[-TE/T2H20_CSF]* [1 – exp (-TR/T1H2O_CSF)]     Equation 4 
RGSH = exp[-TE/T2GSH]* [1 – exp (-TR/T1GSH)]     Equation 5 
where, T2H20_GM = 0.1 s, T2H20_WM = 0.07 s, T2H20_CSF = 0.5 s, T2GSH =0.062 s, T1H20_GM = 
1.65 s, T1H20_WM = 1.1 s, T1H20_CSF = 4.16 s, and T1GSH =0.397 s. These relaxation times were 
estimated from various published studies from other labs (Emir et al., 2011, Ethofer et al., 
2003, Minati et al., 2010). 
fGM, fWM, and fCSF are the fractions of water attributable to GM, WM, and CSF respectively. 
Assuming that the relative densities of MR-visible water in GM, WM, and CSF are 0.78, 
0.65, and 0.97 respectively: 
fGM = [ fGM_vol*0.78 ] / [ (fGM_vol*0.78) + (fWM_vol*0.65) + (fCSF_vol*0.97) ]   Equation 6 
fWM = [fWM_vol*0.65] / [(fGM_vol*0.78) + (fWM_vol*0.65) + (fCSF_vol*0.97) ]   Equation 7 
fCSF = [fCSF_vol*0.97] / [(fGM_vol*0.78) + (fWM_vol*0.65) + (fCSF_vol*0.97) ]   Equation 8 
where fGM_vol, fGM_vol, and fGM_vol are the GM, WM, and CSF volumes respectively determined 
by segmentation.  
3.3.5 Optimisation of method in vitro 
The parameters for the MEGA-PRESS method were optimised in vitro using a phantom of 
concentration 70mM GSH.  Time of echo was optimised for detection of GSH by assessing 
the GSH signal at time of echo of 92, 110, 130 and 145 ms. Pulse duration was optimised by 




3.3.6 Method development for GSH detection in the human brain 
The MEGA-PRESS method was then optimised to detect GSH in the brain in one healthy 
male participant (aged 23 years). The study was approved by University of Birmingham 
ethics committee, and written consent form was obtained from the participant before 
participation. MRS scans were acquired with the participant in the supine position. The 
participant was asked to remain fasted for at least 4 hours and refrain from exercise for 24 
hours prior to each visit. The region of interest was set in the anterior cingulate cortex with 
VOI (30×30 × 20 mm) (as shown in Figure 3-2). In order to optimise the MEGA-PRESS 
parameters, different scans were acquired using different excitation positions (4.40, 4.45, and 
4.56 ppm) of the selective refocusing pulse and different echo times (112, 120 and 130 ms) 
while keeping all other parameters the same. All scans for each parameter being assessed 
were acquired on the same day in the same scanning session. 
3.3.7 Brain GSH through 6 hours 
In order to assess the stability of brain GSH over time, two young healthy males (aged 19 and 
36 years) were scanned four times (using the optimised MEGA-PRESS method) on the same 
day over a 6 hour period. Participants were scanned four times during the 6 hours (at 
approximately 0, 2, 3 and 5 hours from the first scan) starting from early afternoon (13:00 and 
14:30 for the two participants respectively). The second and the third scans were undertaken 
in the same scanning session, i.e. the participant did not come out of the scanner between 
these two scans. The participants were asked not to move throughout the scanning sessions. 
When the participants were outside the scanner in between the scanning sessions (between the 
first and second GSH scan, and the third and fourth scan), the participants were asked to sit 











Figure 3-2 Placement of voxel at region of interest in the brain. 
Representative T1 weighed MRI images of a participant brain illustrating the voxel placement 
at the region of interest in the anterior cingulate cortex with volume of interest (VOI) 30×30 × 









The participants were asked to arrive fasted for at least 4 hours (no food or drink apart from 
water) and refrain from exercise for 24 hours prior to visit. 
3.4 RESULTS 
3.4.1 Declaration of ownership 
Due to the regulations surrounding operation of the scanner, all of the phantom MRS scans 
were undertaken by Dr Alimul Chowdhury, in the presence of the author of this thesis. All of 
the in vivo scans were carried out by Dr Chowdhury or Dr Renate Reniers in the presence of 
the author of this thesis.  All the data analysis presented herein was undertaken by the author. 
3.4.2 In vitro GSH measurement, and assessment of potential GSSG contribution 
GSH produced a single or double positive signal peaks at 2.95 ppm (2.97 and 2.92 ppm) 
dependent on the GSH concentration (as seen in Figure 3-3); higher concentrations produced 
double peaks. A positive correlation was found between the GSH concentration of phantoms 
and the GSH signal measured by the MRS method, as shown in figures A and B in Figure 3-4. 
Repeating the scan of a 70 mM GSH phantom on the same day gave a coefficient of variation 
(CV) of 2 %.  
Oxidation of GSH phantom by addition of H2O2 resulted in decreased GSH signal at 2.95 










Figure 3-3 In vitro measurement of GSH in phantoms 
A spectrum acquired in the absence of the editing pulse (edit-off spectrum). Arrows pointing 
to the respective metabolites: Ch, choline at 3.19 ppm; Cr, creatine at 3.02 ppm; GSH, 
glutathione at 2.92 and 2.97 ppm; and NAA, N-aceylaspartate at 2.01 ppm. Doublet GSH 















Figure 3-4 Measurement of GSH signal from phantoms of various GSH concentrations. 
A) Graph showing positive correlation between the GSH concentration in the phantoms and 
the GSH signal measured by MRS method.  Open and closed circled phantoms were scanned 
using the same method parameters, but were prepared and scanned separately (months apart). 
Squared phantoms data were scanned using different scan parameters to that of circled 
phantoms.  B) Superimposed spectra of edited GSH signals (i.e. edit-on and edit-off spectra 
subtracted) of three phantoms with GSH concentrations of 14 mM (blue arrow), 30 mM 
































Figure 3-5 Oxidation of GSH by addition of H2O2. 
A 30 mM GSH phantom before (a) and after (b) oxidation by addition of H2O2. On oxidation, 













3.4.3 Quantification of GSH using jMRUI 
Other metabolites, other than GSH, were quantified from the edit-off spectra (all the edit-off 
spectra of a scan were summed). Metabolites such as Cr and Ch could be quantified 
automatically using the peak fitting algorithm AMARES in jMRUI as shown in a 30 mM 
GSH phantom Figure 3-6 (AMARES was set for 35 peaks). In higher GSH concentration 
phantoms as in Figure 3-6, AMARES was able to automatically pick and quantify the GSH 
peaks in the edit-off spectra. However, in phantoms with low GSH concentrations at around 
14 mM (which is closer to physiological concentrations), AMARES did not pick the GSH 
peak as the size of the peak was very small and the peak also overlapped with the Cr peak 
(data not shown). 
In order to quantify GSH, the edit-on spectra were subtracted from the edit-off spectra as 
shown in Figure 3-7. Subtraction resulted in the removal of most metabolites, leaving GSH 
and some other residues. The GSH peak was selected manually using ER filter and was 
quantified using AMARES (AMARES was set to 1 peak). 
3.4.1 Optimisation of method in vitro 
In order to refine the MEGA-PRESS method for better GSH detection, parameters (time of 
echo and pulse duration) of the MRS sequence were assessed, shown in Figure 3-8. An 
optimal MRS sequence for GSH detection was therefore developed, as shown in Figure 3-9 B. 
This sequence was superior in suppressing the GSH peak at 2.95 ppm compared to the pilot 
sequence Figure 3-9 A. This optimised sequence was then used to acquire brain MRS data for 








Figure 3-6 Peak fitting using AMARES 
A) Metabolite peak estimation: Automatic peak fitting in jMRUI using the algorithm 
AMARES to quantify major metabolites such as N-aceylaspartate (peak numbered 3), 
creatine (peak numbered 10) and choline (peak numbered 12) in a spectrum obtained from a 
phantom containing 30 mM GSH. GSH peaks are numbered 8 and 9. B) Panel showing 














Figure 3-7 In vitro GSH quantification 
GSH editing in a 20mM GSH phantom in spectra acquired using the optimised sequence 
parameters: (a) unsuppressed frequency spectrum (edit-off spectrum); (b) spectrum with 
MEGA-suppression (edit-on spectrum); (c) edited spectrum obtained on subtraction of 
spectrum (b) from (a). Arrow pointing to the GSH signal obtained on subtraction. Ch, choline 










Figure 3-8 MRS sequence development in vitro 
A) Graph showing exponential curve fit as a function of echo time used and GSH signal 
obtained using the MEGA-PRESS method. B) Graph showing relationship between pulse 




























































Figure 3-9 Comparison of developed MRS sequence 
Spectra obtained using pilot sequence (A) and the developed sequence (B) in a phantom 
containing 60 mM GSH. Unsuppressed frequency spectrum (edit-off) and suppressed 
spectrum (edit-on) are superimposed. Thin arrows pointing to the double GSH peaks obtained 
in the unsuppressed edit-off spectrum. Thick arrows (blue) pointing to suppressed GSH peak 
obtained in the suppressed edit-on spectrum. Developed sequence (B) is superior in 












3.4.2 Method development for GSH detection in the human brain 
MRS sequence development for optimal detection of GSH in the brain was undertaken as 
described in section 3.3.6 section. The highest GSH signal was obtained with excitation at 
4.56 ppm (Figure 3-10). Repeating the scan at 4.56 ppm excitation on a different day gave a 
CV of 17 %. The level of GSH signal measured across the various time of echo were similar- 
CV% was 4 % (shown in Figure 3-10).  
After assessing the results from in vivo and in vitro experiments, the acquisition parameters 
for the MRS MEGA-PRESS sequence for data collection were set as follows: NSA = 8, 
dynamics = 128, echo time = 130 ms, TR = 1800 ms, pulse duration = 40 ms, phase cycles = 
16, water suppression = vapour, water NSA = 32. It took 45 minutes to run the scan with this 
sequence, excluding the initial preparation time such as the structural scan. Figure 3-11 shows 










Figure 3-10 MRS method development in vivo 
A) Graph showing the detection of GSH at various excitation frequency position of the 
selective 180° pulse for cysteine residue while keeping other experimental parameters the 
same. Closed circles data were collected on the same day, while open circle was collected on 
a different day. B) Graph showing the detection of GSH using different time of echo while 
keeping other experimental parameters the same. All scans for each parameter were acquired 










































Figure 3-11 In vivo GSH quantification 
(a) Unsuppressed frequency spectrum (edit-off); (b) suppressed spectrum (edit-on); (c) edited 
spectrum derived by subtraction of spectrum (b) from (a); (d) spectrum (c) multiplied by a 
factor of three. Arrow pointing to the GSH signal obtained on subtraction. Data was acquired 








3.4.3 Brain GSH through 6 hours 
Figure 3-12A shows the mean brain GSH level over a 6 hour (at 0, 2, 3, and 5 hours from the 
first scan) period of two participants. Scans at time 2 hour and 3 hour were acquired in the 
same scanning session (i.e. the participant did not come out of the scanner in between these 
two scans). As can be seen in Figure 3-12A the GSH concentration did not change across time 
except the 3rd scan in one of the participants (closed circles). The CV for the four scans were 
19 % (open circles) and 74 % (closed circles) respectively. The CV% for NAA/water for the 
two participants were 7% (open circles) and 26% (closed circles) respectively.  Assessment of 
the NAA/water signal (shown in Figure 3-12B) detected an increased NAA/water at the 3rd 
scan in one of the participants (closed circles), which suggests that this was a ‘noisy’ scan. 
The concentration of other metabolites such as Cr and Ch also showed similar pattern of CV 










Figure 3-12 Brain GSH through 6 hours 
A) Brain GSH through 6 hours in two participants. B) NAA/water signal of the two 









































Using the MEGA-PRESS technique, measurement of GSH was optimised firstly using in 
vitro experiments. The measured GSH signal positively correlated to the GSH concentrations 
in the phantoms, which confirmed that the observed signal was GSH and that GSH could be 
successfully quantified using this technique. The results of the experiments presented herein 
suggest that the detected GSSG signal did not contribute to the detected GSH signal. This is 
largely in agreement to that observed by others at similar GSH concentrations (Satoh and 
Yoshioka, 2006, Terpstra et al., 2006). Oxidation of the GSH phantom with H2O2 resulted in 
decreased GSH signal at 2.95 ppm and the appearance of a new peak at 3.24 ppm in the 
spectrum, which suggested that GSH has been oxidised to GSSG. In agreement, Satoh and 
Yoshioka (2006), also using MEGA-PRESS, reported that the signal from GSSG was 
distinctive to that from GSH and that under normal conditions (GSH:GSSG ratio = 100:1) the 
GSSG signals were negligible, while at condition of strong oxidative stress (GSH:GSSG ratio 
= 10:1) the GSH signal was prominent and the GSSG signal was faint. While at GSH:GSSG 
ratio of 1:1, they found that the GSSG signal was pronounced and interfered with the GSH 
signal– however, this is a very extreme condition where neurons cannot survive (Satoh and 
Yoshioka, 2006). Therefore, it can be concluded that GSSG did not contribute to the GSH 
signal detected in the human participants that were scanned in the experiments described 
herein. 
The MEGA-PRESS method for GSH detection in the brain was optimised in a male 
participant, by assessing various MEGA-PRESS parameters (time of echo and excitation 
position of the selective refocusing pulse). It was found that 4.56 ppm was the best excitation 
position of the selective refocusing of 180° pulse for the cysteine residue. This is in contrast 




position and that 4.56 ppm gave the most inferior GSH spectra. The difference in the findings 
may be explained by variations in the settings and the methodology (including scan 
parameters such as time of echo and time of relaxation) used between the two studies.  
The data presented herein suggests that brain GSH measured by MRS is reproducible using 
the method described herein. In vitro measurement of GSH in phantoms on two separate 
occasions on the same day gave a CV of 2 %.  Repeat measurement of brain GSH on a 
different day and on the same day gave CV of 17 % and 22 % respectively. This CV of 22 % 
of brain GSH measured over 6 hour period indicate that brain GSH is stable over this period. 
Of the two participants scanned in this time course experiment, GSH levels in one participant 
were stable across 6 hours (CV 19 %), whereas in the other participant brain GSH appear to 
increase at the 3rd scan thus giving an overall CV 74 %.  Other metabolite concentration (with 
reference to water) showed similar patterns in the respective participants and CV i.e. 
increased concentration at scan 3. It is highly likely that this increase observed in the 3rd scan 
in one of the participant is due to noise arising from scanner instability, physiologic motion 
(such as cardiac and respiratory activity) or both (Jansen et al., 2006, Lange et al., 2012). 
Although the measurement of brain GSH using the MRS method is sensitive to noise, the data 
presented suggests that brain GSH can be successfully measured repeatedly using this 
method. The data indicate that brain GSH is stable with time. Terpstra et al. (2011) have also 
reported brain GSH levels to be stable over a 24 hour period.  
3.5.1 Post-processing and signal quantification 
GSH concentration was quantified using jMRUI software. One of the limitations during 
quantification was that the GSH peak was selected manually before quantification by 
AMARES, which could lead to subjective bias. To avoid subjective bias as much as possible, 




AMARES fitting for quantification in jMRUI requires some prior knowledge and some 
degree of manual input. Spectral quantification methods that use predefined models of 
spectral peak fitting such as LCModel have previously been used for quantifying GSH 
(Opstad et al., 2003, Terpstra et al., 2003, Terpstra et al., 2011, Wood et al., 2009). In 
comparison to LCModel software, jMRUI requires user interaction. Although LCModel is 
potentially better for the analysis of 1H-MRS spectra (Mullins et al., 2014), relatively little 
work has been undertaken in measuring GSH using LCModel. The majority of work using 
this method of metabolite quantification has been undertaken in GABA quantification. 
Quantification of GABA acquired using MEGA-PRESS also has similar issues (as with GSH) 
of spectral overlap with other larger metabolites. GABA quantification has various predefined 
spectral peak fitting models such as LCModel, TARQUIN, and QUEST (in jMRUI), as well 
as custom-written GABA-MRS analysis software (Gannet) (Mullins et al., 2014). A study 
which assessed the reliability of these various quantification methods reported that the 
reproducibility of metabolite quantification (for GABA and also Glx: glumate+glutamine) 
was similar across AMARES (in jMRUI), Gannet, LCModel, and TARQUIN (O'Gorman et 
al., 2011). This suggests that jMRUI could have similar efficiency for GSH quantification as 
LCModel. 
3.5.2 Tissue water as concentration reference 
Tissue water was used as the concentration reference for the GSH data presented herein. 
External referencing (such as by simultaneously scanning known concentration of phantoms) 
may be prone to system instability, whereas the water and metabolite signal comes from the 
same voxel scanned and are acquired essentially in the same way (Mullins et al., 2014). The 
advantage of using tissue water as reference is that it removes potential sources of error that 




Additionally, a large multicentre study which compared between external reference placement 
and internal water reference methods reported that the internal water reference gave better 
precision and inter-laboratory reproducibility (Keevil et al., 1998). Furthermore, in the 
method developed herein, the internal water concentration of GM and WM were taken into 
account.  
3.6 CONCLUSION 
An optimised MEGA-PRESS method was developed for the detection of GSH in the brain. 
The findings presented here suggest that GSSG does not contribute to the GSH signal as 
detected by this method. Repeated scanning within and between days indicated 









4 CHAPTER 4: Effect of acute exercise on markers of oxidative 





The brain is highly susceptible to oxidative stress due to its high metabolic demand. In this 
study, the effect of acute exercise bouts on brain glutathione (GSH) in humans was measured 
for the first time. Brain GSH was measured using magnetic resonance spectroscopy (MRS), 
examining an anterior cingulate cortex voxel. To add context to these measures, GSH levels 
and other markers of oxidative stress were also assessed in the periphery (in blood) at three 
time points [pre-, immediately post- and post (~1 hour)- exercise]. In a cross-over design, 
young healthy sedentary males (n = 9) undertook a bout of continuous moderate exercise 
(65% workload max for 40 mins) and a high intensity interval (HII) exercise bout (200% 
workload max for 30 s with 4 mins recovery * 4 cycles) on separate days. In addition, in a 
time-course study, brain GSH was monitored for 6 hours in response to the moderate exercise 
trial (n = 4 exercise). Moderate exercise caused a significant decrease in brain GSH from 8.24 
± 1.59 mM/kg to 4.74 ± 1.13 mM/kg (n = 7, p = 0.002). Blood GSH levels increased 
immediately post-HII exercise, 580 ± 101µM to 692 ± 102 µM (p = 0.006). Total antioxidant 
capacity significantly increased post (~1 hour)-HII exercise from 1,125 ± 187 µM to 1,351 ± 
152 µM (p = 0.003). Measure of lipid peroxidation (MDA levels) decreased post (~1 hour)-
HII compared to immediately post-HII (11.6 ± 3.8 µM from 17.1 ± 9.9 µM, p = 0.01). The 
finding from this small cohort study suggests that an acute exercise caused a decrease in brain 
GSH, however statistical assessment is challenging due to the small sample size and the 
limitation of the MRS method. In blood, HII elicited a greater oxidative stress response 





The human brain is highly susceptible to oxidative stress as it consumes approximately 20 % 
of the oxygen utilised by the body although it only constitutes 2 % of the body weight.  It has 
a high iron content that can catalyse ROS generation (Dringen, 2000). GSH is an antioxidant 
whose depletion can contribute to oxidative stress, and oxidative stress has been identified in 
the pathogenesis of various diseases affecting the brain such as Alzheimer’s disease and 
Parkinson’s disease (Aoyama and Nakaki, 2013). Decreased brain GSH, measured by MRS, 
has been reported in ageing (Emir et al., 2011) and in diseases such as Alzheimer’s Disease 
(Mandal et al., 2012), epilepsy (Mueller et al., 2001) and schizophrenia (Do et al., 2000). 
Thus, a therapeutic strategy to increase the concentration of brain GSH, would therefore be 
desirable in these disorders.  No therapeutic drugs are available for increasing brain GSH 
levels at present (Aoyama and Nakaki, 2013). 
The synthesis of GSH from its constituent amino acids involves two ATP-requiring enzymatic 
steps: i) the first and the rate limiting step is the formation of γ-glutamylcysteine from 
glutamate and cysteine, and then ii) formation of GSH from γ-glutamylcysteine and glycine. 
The highest levels of GSH are found in the liver, and approximately 1/3 to 1/2 of this GSH in 
the liver serves as a cysteine reservoir that can be released into the blood as necessary. The 
majority of GSH produced by the liver does not reach the brain due to the brain blood barrier 
(BBB) where it can penetrate only poorly by passive diffusion. Cysteine is also unable to 
penetrate the BBB, however, the disulfide form with two cysteines called cystine is capable of 
passing the BBB into the CSF via the transporter LAT1. The inability of most cell types to 
effectively import intact GSH suggests de novo GSH biosynthesis is necessary to maintain 




tissues (Dringen, 2000).  Cell-to-cell metabolic interaction occurs in the brain- with astrocytes 
providing precursor amino acids to neighbouring neurons necessary for GSH biosynthesis.  
Export of intact GSH from blood into the brain is unlikely to influence GSH levels in the 
brain (Zeevalk et al., 2008)  and notably, blood makes up only around 3% of the volume in 
the brain (Holmay et al., 2013). Over the last decades numerous studies in humans have 
shown that acute exercise alters peripheral redox status including that of GSH system (Fisher-
Wellman and Bloomer, 2009), however, to assess this in the brain is challenging due to 
difficulty in accessing the brain and in acquiring samples from the brain. In rodents, exercise 
training has been shown to increase brain GSH levels (Ohkuwa et al., 1997). MRS is an 
emerging technique to measure brain GSH. Although this method has its limitations, 
especially in its ability to measure transient changes in brain metabolites, recently a small 
proof-of-concept pharmacodynamics study reported measurement of increased brain GSH 
using MRS method in humans (Holmay et al., 2013).  
Radak et al. (2005) extended the hormesis theory to the free radical generating effects of 
exercise, encompassing a low-dose stimulation or beneficial effect through to a high-dose 
inhibitory or toxic effect. Hormesis relating to free radical generation can be affected by 
parameters such as exercise duration, intensity and frequency in addition to training status. 
Therefore, assessing the effect of each exercise parameter on radical species may be a crucial 
step in determining the ‘best’ exercise strategy for optimising brain structure and function 
(Lucas et al., 2015). Two epidemiological studies reported exercise intensity to be more 
important than exercise duration in preventing cardiovascular disease (Tanasescu et al., 2002, 
Wisloff et al., 2006), and there is evidence to suggest that exercise intensity is a determinant 
of the magnitude of free radical formation in the bloodstream  (Bailey et al., 2004, Lamprecht 




HII exercise involves repeatedly exercising at a high intensity for between 30 seconds and 2 
minutes, with each high intensity interval separated by 1-5 minutes of recovery consisting of 
rest or low intensity exercise. HII involves substantially lower time commitment and reduced 
total exercise volume, and some people suggest this form of exercise is more enjoyable 
compared to longer sessions of moderate-intensity continuous exercise (Gibala et al., 2012). 
Emerging evidence indicates that HII provides equivalent if not indeed superior metabolic 
(Burgomaster et al., 2008, Little et al., 2010, Molmen-Hansen et al., 2012, Sijie et al., 2012, 
Trapp et al., 2008) and cardiac (Currie et al., 2013, Guiraud et al., 2012b, Lalande et al., 2010, 
Weston et al., 2014, Wisloff et al., 2007) adaptions. None of the previous studies have looked 
at the effect of HII in the brain. 
The maintenance of adequate cerebral blood flow (CBF) to the metabolically active brain is 
critical to maintain a constant supply of oxygen and nutrients (Murrell et al., 2013). Exercise 
exerts a different response in the cerebral vasculature compared to that in the peripheral 
vasculature (Ogoh and Ainslie, 2009). During low to moderate intensity exercise there is an 
elevation in CBF, up to an exercise intensity of around 60% of maximal oxygen uptake, after 
which CBF decreases despite the cerebral metabolic demand. During higher intensity 
exercise, the changes in global CBF are not matched with brain neuronal activity and 
metabolism (Ogoh and Ainslie, 2009). Even though HII has been shown to have superior, if 
not equivalent, adaptation benefit to cardiovascular health as mentioned previously, no 
previous study has looked at CBF in response to HII exercise. Assessing HII induced CBF 
response has the potential to reveal i) the underlying mechanism of improved cardiovascular 
and metabolic benefits of HII compared to continuous exercise, and ii) the mechanisms 




The aim of the study was to investigate the effect of an acute bout of HII exercise versus 
continuous (steady state) moderate exercise on GSH in the brain. To give context, markers of 
oxidative stress and BDNF (the most abundant growth factor in the brain) were assessed in 
the blood. CBF was measured during the two types of exercise to investigate any linking 
mechanism between the periphery and the brain in response to the exercise bouts. To our 
knowledge, this is the first study to assess the effect of exercise on brain GSH. Also, this is 
the first study to look at the effect of HII on CBF.  
4.3 METHODS 
4.3.1 Participants 
Healthy males who did not undertake in more than 2 hours of moderate exercise per week 
were recruited to this study. Nine participants were recruited to the cross-over study, and an 
additional four participants were recruited to the time-course study. Participants had not taken 
vitamin supplements for at least six weeks prior to recruitment and were healthy as assessed 
by a general health questionnaire. Participants, who were scanned (n = 8), also had to be free 
from any contraindication to be able to undertake an MRI scan, such as having metal 
implants. All participants gave written informed consent. The study was approved by the 
University of Birmingham ethics committee.  
4.3.2 Cross-over exercise study 
Participants (n = 9) visited the laboratory to undertake exercise having been asked to fast for 
at least 4 hours prior to each visit. Participants were also asked to refrain from exercising and 
drinking alcohol 24 hours prior to the visits. All 3 visits were separated by at least 3 days. All 




exercise bouts, but only four participants were assessed for brain GSH due to costs. The MRS 
scans were started between 17:00 and 19:30.  
A schematic diagram of the study protocol is presented in Figure 4-1. For the first visit, 
participants were accompanied to the Birmingham University Imaging centre (BUIC) (around 
10 minutes walk from the exercise laboratory), where they undertook an MRS scan (baseline 
scan) to assess brain GSH. After the scan, the participants returned to the exercise laboratory 
to carry out a graded exercise test (max test) on a cycle ergometer by cycling to volitional 
exhaustion. Maximal oxygen consumption (V̇O2max) and maximum work load were 
calculated from this test.  
During the second and the third visit, the participants took part in either HII exercise or a 
continuous moderate exercise (the sequence of the exercise trial was counterbalanced between 
participants). Following arrival to the lab, an indwelling catheter was inserted into an 
antecubital vein in the forearm, which was kept patent by flushing regularly with saline. A 
pre-exercise blood sample was taken. Blood flow velocity of the middle cerebral artery 
(MCAv) was then assessed by transcranial Doppler (TCD) for 3 minutes at rest while sitting 
on a chair. The participant then began the exercise trial. Following the exercise bout, a blood 
sample was immediately taken (immediately post-exercise sample) by the catheter. The 
participant then walked to BUIC for a post-exercise MRS scan for brain GSH measurement. 
A final blood sample (post-exercise sample) was taken by venepuncture ~1 hour after end of 
exercise.  
4.3.3 Time course study: the effect of exercise on brain GSH across a time-course  
To investigate brain GSH levels 4 hours post-acute exercise, an additional four participants 








Figure 4-1 Schematic diagram of cross-over exercise study 
BUIC, Birmingham University Imaging Centre; MRS, magnetic resonance spectroscopy; and 








approximately 0, 2, 3 and 5 hours from the first scan), starting in the afternoon between 13:00 
to 17:00. A schematic diagram is presented in Figure 4-2. Participants took part in continuous 
moderate exercise as described in the “Exercise trials” in 4.3.4 after completing the first scan. 
Immediately after the end of the exercise, participants were taken to the scanner for the 
second scan. The second and the third scans were undertaken in the same scanning session, 
i.e. the participant did not come out of the scanner between these two scans. The participants 
were asked to come fasted for at least four hours prior to the visit. When the participants were 
outside the scanner in between the scans, the participants were free to do anything as long as 
they did not take part in strenuous physical activity (participants usually used/worked on their 
electronic or smart devices). 
4.3.3.1 Effect of acute moderate exercise on brain GSH  
Overall 8 participants were scanned post-moderate exercise, four took part in the cross-over 
study (baseline scan having been done prior on a different day) and four participants in the 
time-course study (baseline scan carried out on the same day before starting exercise). The 
brain GSH results from these 8 data sets with their respective control/baseline measurement 
were assessed for statistical difference.  
4.3.4 Exercise trials 
All exercise tests were performed on a cycle ergometer (Lode Excalibur Sport, Netherlands). 
Max test (incremental exercise test starting at 60 W and increasing by 35 W every 3 minutes 
until exhaustion) was undertaken to calculate individual V̇O2max, during which breath-by-
breath measurements (Oxycon Pro, Jaegar, Germany) were recorded. Heart rate was 
monitored (using Polar, Finland)  throughout the bout, and rating of perceived exertion (RPE) 
























Workload max = last completed work load + (time spent in the final non-completed work rate 
´ work rate increment) 
Schematic representation of the HII and the continuous moderate exercise trials are shown in 
Figure 4-3. The HII exercise trial consisted of cycling at 200 % workload max for 30 seconds 
with 4 minutes recovery time with 4 cycles (18 minutes total time). The continuous moderate 
exercise trial consisted of continuous cycling at 65 % workload max for 20 minutes and then 
at 55 % workload max for last 20 minutes (total 40 minutes) [the work load was decreased in 
the last 20 minutes to match the oxygen consumption in the first 20 minutes (Hagberg, Mullin 
and Nagle, 1978)]. Both exercise bouts were preceded with a warm up (3 minutes) and 
followed by a cool down (2 minutes for continuous moderate bout) cycling at 40 % workload 
max. 
4.3.5 Measurement of brain GSH 
GSH was measured in the brain at anterior cingulate cortex using MRS method as described 
in chapter 3. In brief, acquisition parameters for the MEGA-PRESS were as follows: NSA = 
8, dynamics = 128, echo time = 130 ms, TR = 1800 ms, pulse duration = 40 ms, phase cycles 
= 16, water suppression = vapour, water NSA = 32. 
4.3.5.1 Analysis: Quantification of brain GSH 
Brain GSH quantification from the MRS scans were undertaken as described in chapter 3.  
4.3.6  Markers of oxidative stress and other biomarkers in blood 
Blood samples (6 ml) were collected in EDTA vacutainers. For GSH analysis, blood samples 





Figure 4-3 Schematic diagram of the two exercise bouts 
Figure showing schematic diagram of HII and continuous moderate exercise trials. Maximum workload of individual participants were calculated 
from the max test, which was then used to calculate the workload for various phases of the exercise trial as shown in the figure.
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ice until processing for plasma samples by centrifugation at 2,800 rpm for 15 minutes at 4 °C. 
The samples were then stored at -70 °C.  
4.3.6.1 Glutathione 
GSH in whole blood was measured using a commercially available kit (GSH-Glo Glutathione 
Assay V6911, Promega, USA) according to the manufacturer’s instructions. The assay 
quantifies GSH using bioluminescence, based on the conversion of luciferin derivative into 
luciferin in the presence of GSH, catalysed by glutathione S-transferase. In brief, whole blood 
was first lysed with tricine. Then, the supernatant was transferred to multiwell plate with 
luciferin-NT substrate and glutathione s-transferase. After incubation with luciferin detection 
reagent, the luminescence was read. Mean intra-assay CV was 1 %. 
4.3.6.2 Total antioxidant capacity 
Total antioxidant capacity in plasma samples was determined by the FRAP assay as described 
in the general methods chapter (section 2.2.1). 
4.3.6.3 Lipid peroxidation measurement 
4.3.6.3.1 Malondialdehyde (MDA) measurement 
Lipid peroxidation in plasma samples was determined by the MDA assay as described in the 
general methods chapter (section 2.2.2). 
4.3.6.3.2 8-isoprostane 
Additionally, lipid peroxidation was measured in plasma by determining 8-isprostane level 
using a commercially available kit (8-Isoprostane EIA kit 516351, Cayman Chemical, USA). 
This competitive ELISA is based on the competition between 8-isoprostane and 8-isoprostane 
tracer for 8-isoprostane-specific binding (to an antiserum).  In brief, sample (1:1 dilution) and 
standards were incubated with tracer and antiserum in respective wells of the multiwell plate 
that is pre-coated with antibody. After 18 hours incubation, the wells were washed to remove 
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any unbound reagents. Colour was developed using Ellman’s reagent and the absorbance was 
read. The absorbance is inversely proportional to the amount of 8-isoprostane in the 
samples/standards.  Mean intra-assay CV was 8 %. 
4.3.6.4 Protein carbonyl 
Protein carbonyl was measured in plasma samples as described in the general methods chapter 
(section 2.2.4). 
4.3.6.5 Brain derived neurotropic factor: 
BDNF was measured in plasma samples as described in the general methods chapter (section 
2.2.5). 
4.3.6.6 Cerebral blood flow measure during exercise 
Cerebral blood flow (CBF) was assessed in response to the two exercise trials in the 4 
participants who took part in the cross over study, in section 4.3.2. MCAv was assessed using 
TCD as described in general methods chapter (section 2.3).  Participants breathed through a 
respiratory mask attached to a Y-shaped two-way non-rebreathing valve. Breath-by-breath 
pressure of end-tidal CO2 (PETCO2) was sampled from the mask and measured using a gas 
analyser. Cerebrovascular hemodynamics (MCAv) and respiratory variable were acquired 
continuously using an analog-to-digital converter (Powerlab; ADInstruments) interfaced with 
a computer, and were subsequently analysed using commercially available software (Lab 
Chart, ADInstruments). 
4.3.7 Statistical Analysis 
Data were inspected for normal distribution using the Shapiro-Wilk test. Data which were not 
normally distributed were either transformed for normal distribution prior to statistical 
analyses (for example FRAP) or were tested using appropriate non-parametric tests. Analysis 
on the effect of exercise bouts on brain GSH were assessed using one-way repeated measure 
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analyses of variance (ANOVA). Analyses on the effect of two exercise trials (HII and 
moderate exercise trial) at each of the three time points (pre-, immediately post- and post (~1 
hour)- exercise) on markers of oxidative stress and BDNF levels in the blood/plasma were 
performed using a two-way repeated measure ANOVA.  Where appropriate, post hoc 
analyses were conducted to explore the main effects in more detail. Statistical significance 
was accepted at the p<0.05 level. Data were analysed using SPSS 22.0 statistical package for 
Windows (SPSS Inc, USA). Data are presented as means ± standard deviation of the mean 
(SD), unless otherwise stated. 
4.4 RESULTS 
4.4.1 Declaration of ownership 
 Due to the regulations surrounding operation of the scanner, all of the MRS scans were 
carried out by Dr Alimul Chowdhury or Dr Renate Reniers in the presence of the author of 
this thesis.  All the data analysis presented herein was carried out by the author. 
4.4.2 Participants 
Table 4.1 shows the participant demographics.  
4.4.3 Effect of exercise on brain GSH 
4.4.3.1 Effect of HII and moderate exercise on brain GSH  
The result in Figure 4-4 shows brain GSH post-exercise (HII and moderate bout) compared to 
control/baseline GSH concentration (without any exercise). One-way repeated measure 
ANOVA showed that exercise caused a significant difference in brain GSH F (2, 6) = 29.19, p 
< 0.01. Bonferroni post-hoc analysis showed a significant decrease in GSH level post-
moderate exercise compared to baseline, 9.15 ± 1.45 mM/kg to 4.68 ± 1.47 mM/kg (p = 
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Figure 4-4 Effect of HII and moderate exercise on brain GSH 
Brain GSH levels were measured post-exercise (HII or moderate exercise) and compared with 
control/baseline (without exercise) measurement, carried out on separate days (n = 4). 
Pairwise comparisons: * indicates significant difference relative to control and † indicates 















































HII GSH, 8.52 ± 1.61 (p = 0.031). 
4.4.3.2 Monitoring the effect of exercise on brain GSH over 4 hours post-exercise 
Figure 4-5 A shows the time course of GSH measured over six hours, including four hours 
post-exercise (n = 3). Out of 4 participants assessed, one participant was removed due to 
noisy signal; the NAA/water signal CV % was 31 % (NAA/water signal CV % for other 
participants were less than 14 %). GSH was measured before exercise and at 3 different times 
post-exercise. Figure 4-5 B shows additional data from the time course study (presented in 
Chapter 3 section 3.4.6) where the participants did not do any exercise. 
4.4.3.3 Effect of acute moderate exercise on brain GSH level 
Data from the 7 participants who were scanned post-moderate exercise (n = 3 time-course 
study with control and post-exercise scans undertaken on the same day; and n = 4 cross-over 
study with control and post-exercise scans undertaken on different days) were tested for 
statistical difference in brain GSH (Figure 4-6). Paired sample t-test showed that there was a 
significant decrease in GSH following moderate exercise from 8.24 ± 1.59 mM/kg to 4.74 ± 
1.13 mM/kg, t (6) = 5.24, p = 0.002. There was no difference in baseline GSH levels between 





Figure 4-5 Monitoring the effect of exercise on brain GSH through 6 hours 
A) Brain GSH was monitored for 6 hours in response to an acute moderate exercise (n=3). 
Exercise was undertaken after the first scan, after which the participant immediately went 
back to the scanner for the second scan. The black and the grey line represents mean data and 
individual data respectively. B) Mean data of participant who took part in moderate exercise 
(from graph A, n = 3) and control participants who did not exercise (data from chapter 3, n = 















































Figure 4-6 Brain glutathione in response to moderate exercise   
Brain GSH was measured at baseline (without exercise) and after moderate exercise (post-
exercise) (n = 7). Three participants (open circles) undertook the exercise on the same day 
after the baseline measurement. Four participants (closed diamonds) undertook the exercise 
on a different day after the baseline GSH measurement. Horizontal line represents the mean of 
all participants. There was significant decrease in GSH concentration from control to post-





















4.4.4 Markers of oxidative stress and other biomarkers in blood of the cross-over 
study 
4.4.4.1 GSH in whole blood 
GSH was assessed in whole blood [pre-, immediately post- and post (~1 hour)- exercise] in 
response to the two different exercise bouts (n = 8) (Figure 4-7). A two-way repeated measure 
ANOVA showed that there was a significant main effect of the type of exercise trial 
(moderate and HII) on GSH level, F (1, 7) = 14.8, p = 0.006.  Similarly, there was significant 
main effect of time on GSH level, F (2, 14) = 7.0, p = 0.008, and contrasts revealed that the 
significant difference was between pre- and immediately post- exercise GSH levels (p = 
0.004). There was a significant interaction effect between the type of exercise and the time 
point on GSH, F (2, 14) = 9.22, p = 0.003. Contrasts revealed a significant difference between 
pre- and immediately post- exercise comparing the two exercise trials, F (1, 7) = 31.4, p = 
0.001.  
Comparison of the two exercise trials at each time points revealed a significant difference in 
GSH levels at immediately post-exercise (692 ± 102 µM for HII and 598 ± 90 µM for 
moderate exercise), F (1, 7) = 20.1, p = 0.003. Whereas, there was no significant difference at 
pre-exercise (p = 0.63) and a borderline significant difference at post (1~ hour)- exercise 
(0.05) in GSH levels. Further analysis of the individual exercise trial (moderate and HII) 
using one-way ANOVA revealed that a significant increase in GSH level occurred at 
immediately post- HII exercise from the pre-HII level (692 ± 102 µM from 580 ± 101µM), p 
= 0.006. 
4.4.4.2 Total antioxidant capacity 
Figure 4-8 shows total antioxidant capacity in plasma [pre-, immediately post- and post (~1 








Figure 4-7 GSH in periphery 
GSH in whole blood was measured in response to the two exercise bouts (n = 8). # indicates 
significant difference between pre and immediately post levels comparing the two exercise 
bouts (HII and moderate exercise). Pairwise comparisons: § indicates significant difference 


































Figure 4-8 Total antioxidant capacity 
Mean plasma total antioxidant capacity pre-, immediately post- and post (~1 hour)- exercise 
(n = 8). Data was ln10 transformed for normal distribution.  # indicates significant difference 
between pre and post levels comparing the two exercise bouts (HII and moderate exercise). 
Pairwise comparisons: § indicates significant difference between the two exercise bouts and * 
indicates significant differences at the post (~1 hour)-exercise, relative to pre-exercise for the 









normally distributed, data was normalised by ln10 transformation. A two-way repeated 
measure ANOVA showed that there was a non-significant main effect of the type of exercise 
trial on antioxidant capacity, F (1, 7) = 4.21, p = 0.079. Whereas, there was a significant main 
effect of time, F (2, 14) = 5.3, p = 0.02, and contrast revealed that the significant difference 
was between pre- and post (~1 hour)- exercise (p = 0.02). There was a significant interaction 
effect between the type of exercise and the time point on antioxidant capacity, F (1.1, 8.08) = 
6.3, p = 0.03. Contrasts revealed a significant difference between pre and post antioxidant 
capacity comparing the two exercise trials, F (1, 7) = 9.18, p = 0.02.  
Comparison of the two exercise trials at each time points revealed a significant difference in 
total antioxidant capacity at post (1~ hour)- exercise (1351 ± 152 µM for HII and 1118 ± 146 
µM for moderate exercise), F (1, 7) = 25.7, p = 0.001. Comparison of total antioxidant 
capacity between the two exercise conditions at pre- and immediately post- exercise were not 
significant (p = 0.78 and p = 0.76 respectively). Further analysis of the individual exercise 
bouts using one-way ANOVA revealed that a significant increase in antioxidant capacity 
occurred post (~1 hour)-HII relative to pre-HII (1351 ± 152 µM from 1125 ± 187 µM) (p = 
0.003). 
4.4.4.3 Lipid peroxidation 
4.4.4.3.1 Malondialdehyde levels 
The result in Figure 4-9 A shows MDA levels (reciprocal transformation) in response to the 
two exercise bouts (moderate and HII) at the three time points: pre-, immediately post- and 
post (~1 hour)- exercise (n = 8). As data was not normally distributed, data was normalised by 
reciprocal transformation. Two-way repeated measure ANOVA showed no significant main 
effect of the type of exercise bout on MDA levels F (1, 7) = 0.35, p = 0.57. There was a 
significant main effect of time, F (2, 14) = 5.58, p = 0.01, however contrasts did not revealed 
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a significant difference in MDA levels when comparing immediately post-exercise and post 
(~1 hour)-exercise with pre-exercise levels. There was a significant interaction effect between 
the type of exercise bout and the time point on MDA levels, F (2, 14) = 5.27, p = 0.02. Further 
analysis using contrasts did not show any significant difference in MDA levels between pre-
exercise level with either immediately post- or post (~1 hour)- levels comparing the two 
exercise trials, F (1, 7) = 4.87, p = 0.06 and F (1, 7) = 1.85, p = 0.22 respectively.  
Comparison of the two exercise trials at each time points did not show any significant 
difference in MDA levels at any of the 3 time points; p = 0.27, p = 0.14 and p = 0.06 at pre-
exercise, immediately post-exercise and post (~1 hour)-exercise respectively. Analysis of the 
individual exercise bouts using one-way ANOVA (Bonferroni) revealed that there was a 
significant decrease in MDA levels post (~1 hour)-HII compared to immediately post-HII (p = 
0.01), to 11.6 ± 3.8 from 17.1 ± 9.9 µM. 
4.4.4.3.2 8-Isoprostanes 
8-Isoprostanes levels in response to exercise are presented in Figure 4-9 B (n =7). Two-way 
repeated measure ANOVA produced no significant main effect of the type of exercise bout on 
isoprostane levels F (1, 6) = 2.61, p = 0.16. Similarly, no significant main effect of time was 
observed in the isoprostane levels, F (2, 12) = 1.42, p = 0.28. There was no significant 
interaction effect between the type of exercise bout and the time point on isoprostane levels, F 
(1.04, 6.26) = 2.64, p = 0.15.  
Comparison of the two exercise trials at each time points did not show any significant 
difference in isoprostane levels at any of the 3 time points; p = 0.85, p = 0.28 and p = 0.09 at 
pre-exercise, immediately post-exercise and post (~1 hour)-exercise respectively. Analysis of 
the individual exercise bouts using one-way ANOVA (Bonferroni) did not show any 






Figure 4-9 Lipid peroxidation 
Lipid peroxidation was estimated by measuring MDA and 8-isoprostane in plasma samples at 
pre-, immediately post- and post (~1 hour)-exercise in response to the two types of exercise. 
A) Mean MDA levels (n = 8). B) 8-Isoprostane (n = 7) levels. 
Pairwise comparisons: * indicates significant difference between immediately post- and post 





















































4.4.4.4 Protein carbonyl  
Changes in protein carbonyls in response to the HII and the moderate trial are shown in 
Figure 4-10 (reciprocal transformed) (n=8). As data was not normally distributed, data was 
normalised using reciprocal transformation. A two-way repeated measure ANOVA showed 
no significant difference in protein carbonyl between the two types of exercise, F (1, 7) = 
0.15, p = 0.71.  Whereas, there was a significant main effect of time in protein carbonyl 
levels, F (2, 14) = 5.02, p = 0.02, and contrasts revealed that the significant difference was 
between pre-and immediately post-exercise levels (p = 0.01). There was no significant 
interaction between time and type of exercise (HII and moderate trial) on protein carbonyl, F 
(2, 14) = 0.62, p = 0.55.   
Comparison of the two exercise trials at each time points did not show any significant 
differences in protein carbonyl levels at any of the 3 time points; p = 0.36, p = 0.72 and p = 
0.44 at pre-exercise, immediately post-exercise and post (~1 hour)-exercise respectively. 
Further analysis of the individual exercise bouts using one-way ANOVA revealed that a 
significant change in protein carbonyl levels in response to moderate trial, F (2, 14) = 3.97, p 
= 0.04. Post hoc comparison (Bonferroni) revealed significant decrease in protein carbonyl 
levels occurred at immediately post- from pre-exercise level in response to moderate exercise 
trial (p = 0.05). 
4.4.4.5 Brain derived neurotropic factor 
Changes in plasma BDNF in response to the two types of exercise trials (n = 9) are shown in 
Figure 4-11 (squared root transformed). As data was not normally distributed, data was 
normalised using squared root transformation. A two-way repeated ANOVA showed no 
significant difference in BDNF levels between the two types of exercise, F (1, 8) < 0.001, p = 








Figure 4-10 Protein carbonyl 
Protein carbonyl levels in response to the two exercise trials (n = 8). Pairwise comparison: * 












































Figure 4-11 BDNF levels 
Plasma BDNF levels in response to the HII and the moderate exercise trial (n = 9). Data was 
squared root transformed for normal distribution. Pairwise comparisons: * indicates 











































contrasts revealed that the significant difference in BDNF levels was between pre- and 
immediately post-exercise (p = 0.006). There was no significant interaction in BDNF levels 
between time and type of exercise (HII and moderate trial), F (2, 16) = 1.77, p = 0.20.   
Comparison of the two exercise trials at each time points did not show any significant 
differences in BDNF levels at any of the 3 time points; p = 0.21, p = 0.15 and p = 0.89 at pre-
exercise, immediately post-exercise and post (~1 hour)-exercise respectively. Further analysis 
of the individual exercise bouts using one-way ANOVA revealed that a significant change in 
BDNF levels in response to HII trial, F (2, 16) = 10.96, p = 0.001. Post hoc comparison 
(Bonferroni) revealed significant increase in BDNF levels occurred at immediately post- 
(2748 ± 1924 pg/ml) and post (~1 hour)- (1448 ± 888 pg/ml) compared to pre-exercise (765 ± 
471 pg/ml) BDNF levels in response to HII trial (p = 0.02 and p = 0.03 respectively). 
4.4.5 Cerebral blood flow in response to the two exercise trials 
Figure 4-12 shows the changes in MCAv in response to the two exercise trials in 3 
participants (one participant was removed because of incomplete data of the whole trial due to 
poor TCD signal) who undertook the cross-over study. Data was analysed by dividing each of 
the exercise trial into 4 parts (i.e. 1st 1/4th, 2nd 1/4th, 3rd 1/4th and 4th 1/4th of the exercise trial). 
Overall the MCAv in response to the two exercise bout seems to be similar across the exercise 
bouts.  
Figure 4-13 shows MCAv changes during the high intensity phases of the HII bout (10 s 
increments) along with warm up/ recovery before the high intensity phase (1 minute average) 
and after the high intensity phase (10 s increments for 60 s after the high intensity phase). 
One-way repeated measures ANOVA was carried out on the MCAv response of all 14 






Figure 4-12 MCAv changes in response to the two exercise trials 
Mean of MCAv during the two exercise trials (HII and moderate bout) divided into 4 parts 



































Figure 4-13 MCAv changes during high intensity phase of HII bout 
MCAv changes during high intensity phases (10s increments) were compared with warm up/ 
recovery before the high intensity phases (1 minute average) and after the high intensity 
phases (10 s increments for 60 s after the high intensity phase).  Solid line  
represents mean of all 14 individual high intensity phases of all the four participants (2 high 
intensity phases of one participant were not included due to poor TCD signal). The dotted line 
(  represents mean of the four participants individually averaged high intensity 
phases data. Pairwise comparisons: * and + indicates significant difference from 1st 10 s of 
high intensity phase (HII 1st 10s in figure) in the 14 individual high intensity phases data and 
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participant were not included due to poor TCD signal) (solid line in figure). There was a 
significant effect of HII bouts on MCAv F (9, 117) = 7.80, p < 0.001. Post-hoc tests using 
Bonferroni corrections revealed that compared to first 10 s of the high intensity phase (HII 1st 
10s in figure), there was a significant decrease in MCAv during the second 10 s of the high 
intensity phase (HII 2nd 10s in figure) (p = 0.003). 
All four high intensity phases of the HII trial of each participant (n = 4) were individually 
averaged (with the exception of one participant whose 2 high intensity phases were not 
included due to poor signal) and then the mean of all four participants are presented as dotted 
lines in Figure 4-13. One-way repeated measure ANOVA showed a significant effect of HII 
exercise on MCAv F (9, 27) = 8.90, p < 0.001. Post-hoc tests using Bonferroni corrections 
revealed that there was a significant decrease in MCAv during the second 10 s of the high 
intensity phase (HII 2nd 10s in figure) (p = 0.04) compared to the first 10s of the high intensity 
phase (HII 2nd 10s in figure). Time series of MCAv and PETCO2  during a high intensity 
phase of a HII bout is shown in Figure 4-14. 
4.5 DISCUSSION 
In this small cohort study, an acute bout of moderate exercise was found to decrease brain 
GSH, an effect that was not seen in response to HII. In contrast, GSH in the periphery was 
increased immediately post-exercise in response to the HII bout whereas there was no 
significant change in blood GSH in response to moderate exercise.  Total antioxidant capacity 
and marker of lipid peroxidation were significantly altered post (~1 hour)-exercise in response 
to HII bout, while moderate exercise elicited a decrease in protein carbonyl immediately post 
exercise. The findings of this study suggest that exercise induced changes in markers of 







Figure 4-14 Time series of cerebral blood flow during a high intensity phase of HII 
exercise 
Time series of MCAv and PETCO2 is shown during one of the high intensity phases (out of 
four) in one of the participant. The first, second and third arrow indicates pre 5 seconds before 




probably independent to that in the periphery. 
4.5.1 Effect of exercise on brain GSH and CBF 
The result from this small cohort study suggests that an acute bout of moderate exercise elicits 
a decrease in brain GSH. Additionally, it seems that a moderate exercise bout had a larger 
effect on brain GSH than HII exercise. However, these results are difficult to interpret due to 
the small sample size and the sensitivity of the MRS method in measuring brain GSH. For 
example movement or motion due to cardiac and respiratory activity can have a large effect 
on MRS quantification (Felblinger et al., 1998, Jansen et al., 2006). The finding from this 
study suggests that the sensitivity of MRS with current available technology limits the ability 
to detect potential changes in brain GSH in response to exercise. A study involving large 
number of individuals is needed to confirm the potential exercise-induced change in brain 
GSH. A power analysis indicated that 46 participants would be required to observe a 0.80 
power (i.e. 1-b = 0.8) with a = 0.05 and partial h2 = 0.1. 
GSH has been reported to have diurnal variation with highest level in the morning and lowest 
level in the afternoon/evening. In humans, some studies have reported diurnal variation of 
GSH in plasma (lowest level early afternoon)  (Blanco et al., 2007, Samuelsson et al., 2011) 
and bone marrow (lowest level in the evening) (Bellamy et al., 1988, Smaaland et al., 2002), 
whereas another study reported no diurnal variation of GSH in the skeletal muscle (Luo et al., 
1995). Such a diurnal variation is unlikely to have a significant effect on the brain GSH 
measured within the study design of the study presented in this chapter. The scans for the 
cross-over study were started in the late afternoon/evening between 17:00 and 19:30. Whereas 
the scans for the time course study (lasting for around 6-7 hours) were started between 13:00 
and 17:00. Furthermore Terpstra et al. (2011) reported no change in brain GSH level 
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measured over a 24 hour period in healthy individuals, suggesting there is no diurnal variation 
in brain GSH. 
There is a wealth of evidence to show that exercise-induced increases in oxidative stress are 
key to adaptive processes (Jackson, 1999, Radak et al., 2008, Ristow et al., 2009). The GSH 
system has been shown to have an adaptive response to exercise training: Elokda and Nielsen 
(2007) found exercise training in sedentary humans increased resting blood GSH. Exercise 
training can act as a stimulus to increase synthesis of endogenous antioxidants like GSH 
(Elokda and Nielsen, 2007, Nyberg et al., 2014) and antioxidant enzymes such as glutathione 
peroxidase (Bogdanis et al., 2013, Elosua et al., 2003, Takahashi et al., 2013). These 
adaptations in response to exercise are well documented in muscle (Hellsten et al., 1996, 
Powers et al., 1999), and occur in response to repeated exercise training. Although no studies 
have established that brain antioxidant levels are higher in trained humans, there is enough 
evidence from whole body studies to suggest that exercise could help maintain redox balance 
in the brain. Exercise training has been shown to decrease protein oxidation (reactive carbonyl 
derivatives) in rat brain (Ogonovszky et al., 2005). A review by Camiletti-Moiron et al. 
(2013) found that moderate aerobic exercise training in rodents promoted the antioxidant 
capacity of brain, while high-intensity or aerobic-exhausted exercise training could deteriorate 
the antioxidant response. The authors of the review did not find any relevant studies in 
humans but they hypothesised that aerobic moderate training is the most appropriate exercise 
to positively enhance the brain antioxidant response. The results presented herein are in 
agreement with this hypothesis, as moderate exercise, rather than HII exercise, caused a 
greater decrease in brain GSH in all of the participants tested. 
As GSH levels were only assessed at the anterior cingulate cortex, there is a possibility that 
exercise could be altering brain GSH levels at other brain regions in a different way. In rats, it 
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has been reported that different brain regions contained different levels of GSH (Somani et 
al., 1995). The anterior cingulate cortex was selected in this study as the activation of this 
region is linked to the physical fitness of individuals (Colcombe et al., 2004) and also this 
region is detrimentally impacted by ageing and dementia (Chapman et al., 2013). 
Furthermore, exercise training has been shown to increase resting CBF in the anterior 
cingulate region (Chapman et al., 2013).  
CBF during the two exercise trials was assessed by measuring MCAv. The MCAv in response 
to the two exercise bouts seemed to be similar when comparing the exercise trials as a whole. 
However, looking at MCAv changes specifically during the high intensity phase of the HII 
exercise showed that there is an instantaneous decrease in MCAv after the initial increase. 
The CBF seems to be protective at high intensity exercise; the brain seems to be protected 
against hyperperfusion during the 30 seconds of high intensity phase of the HII bout probably 
due to exercise-induced hyperventilation hypocapnic effect, as suggested by the significant 
decrease in MCAv compared to the initial increase seen during the short 30 seconds high 
intensity phase. Exercising above ~60% V̇O2max induces a hyperventilation induced 
hypocapnia and the subsequent cerebral vasoconstriction reduces CBF towards the resting 
value; this constrictive effect may serve as a neuroprotective response to prevent BBB 
disruption and hyperfusion injury (Lucas et al., 2015). 
4.5.2 Effect of exercise on markers of oxidative stress and BDNF in the blood 
The effect of exercise on markers of oxidative stress in the periphery seems to be dependent 
on the type of exercise bout. The HII bout elicited a transient increase in blood GSH 
immediately post-exercise. Turner et al. (2011) also reported an increase in GSH level post 
ultraendurance exercise along with increase in other markers of oxidative stress including 
lipid peroxidation, oxidative DNA damage, and protein carbonylation. Similarly other studies 
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have also found increases in blood GSH post-acute exercise (Hessel et al., 2000, Ji et al., 
1993, Subudhi et al., 2003). This transient increase seen in blood is probably due to hepatic 
efflux of GSH (Anderson et al., 1980, Lu et al., 1990) in order to compensate for the ROS 
production during exercise. However, not all studies report increased GSH following exercise.  
Fisher-Wellman and Bloomer (2009) reviewed several studies that either report a decrease or 
no change in blood/plasma GSH levels during or at the end of exercise. These differences 
across studies could well be explained by training status of the participants, and duration, 
mode and intensity of exercise.  
Measures of total antioxidant capacity and lipid peroxidation in plasma were respectively 
increased and decreased post-exercise in response to the HII bout. Whereas, moderate 
exercise elicited a decrease in protein carbonyl immediately post exercise. In contrast to the 
finding of this study, Wadley et al. (2016a) reported a  similar oxidative stress response due to 
HII compared to continuous moderate exercise. This difference in finding is probably due to 
the difference in exercise bout; Wadley et al. (2016a) used a low volume HII of 90 % 
V̇O2max whereas the study presented herein used high volume HII of 200 % V̇O2max. 
Periods of intensive exercise can cause temporary ischemia and hypoxia in certain regions of 
the body and this can result in activation of xanthine oxidase (Sachdev and Davies, 2008). On 
reperfusion, reintroduction of oxygen can result in burst of superoxide  and H2O2 which would 
be expected to result in further oxidation including lipid peroxidation and glutathione 
oxidation (Sachdev and Davies, 2008).  The repeated cycle of high intensity phase during the 
HII trial probably could also be one of the contributing factors for higher oxidative stress 
response seen in the study presented here. The increase in total antioxidant capacity in plasma 
after HII exercise as assessed by FRAP assay is probably due to efflux of vitamin C from the 
adrenal glands into the circulation (Gleeson et al., 1987) and purine nucleotide degradation 
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leading to uric acid production (Green and Fraser, 1988). Uric acid is a main contributor to 
the antioxidant capacity measured by this assay (Cao and Prior, 1998) and the concentration 
of uric acid in plasma has been shown to be dependent on exericse intensity (Green and 
Fraser, 1988). 
Exercise of sufficient intensity and duration can cause acute oxidative stress; various factors 
drive the direction of the response of oxidative stress to exercise including participant 
physiology (such as training status), and the intensity, duration and type of exercise (Wadley 
et al., 2016b). For instance, many studies have reported acute increases protein carbonyl in 
response to exercise, while some studies have found decrease in protein carybonyl (Wadley et 
al., 2016b), including the study presented herein. Wadley et al. (2016b) suggest that exercise 
may stimulate the clearance of plasma protein carbonyl present at baseline, whereas 
simultaneously increasing ROS production that facilitates the formation of new protein 
carbonyl groups. The balance between the formation and the clearance processes (probably 
involving 20S proteasome system) following exercise likely explains the increase, decrease or 
no change in plasma protein carbonyl level in response to exercise reported across studies 
(Wadley et al., 2016b). 
Plasma BDNF increased in response to HII exercise but not moderate exercise. This finding is 
in agreement with the study by Ferris et al. (2007), who reported that peripheral BDNF levels 
increased in response to exercise and this increase was correlated with exercise intensity. 
BDNF is the most abundant growth factor in the brain and is often thought to be a link 
between exercise and improved brain health. A review by (Knaepen et al., 2010) indicates that 
acute aerobic exercise causes a transient increase in basal peripheral BDNF concentration, and 
thus could be an important modulator of the beneficial effects of exercise for the brain. BDNF 
levels are increased not only in the brain and plasma due to exercise, but also in skeletal 
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muscle during contraction (Pedersen et al, 2009). However, BDNF produced in muscle is 
probably not released into the circulation (Pedersen et al, 2009). 
4.5.3 Comparing the response between the periphery and the brain 
The effect of exercise on markers of oxidative stress was dependent on the intensity of the 
exercise bout in both the brain and the periphery.  However, it seems that the effect in the 
brain may be independent to the periphery, as the oxidative stress response to exercise 
intensity in the blood and the brain showed contrasting responses. Only the moderate trial 
induced a decrease in brain GSH, whereas in the periphery the HII trial was the most effective 
in inducing changes in oxidative stress markers. As introduced earlier, the majority of GSH 
produced in the liver does not reach the brain due to the BBB, suggesting de novo GSH 
biosynthesis in the brain.  
Exercise training studies in rats have suggested that brain and blood GSH are related, 
although studies report differences in their findings (Itoh et al., 1998, Ohkuwa et al., 1997). 
For example, Ohkuwa et al. (1997) observed that moderate exercise training increased both 
brain and plasma GSH levels in rats, whereas Itoh et al. (1998)  did not find any effect of 
training on both plasma and brain GSH levels. Although contradictory in the direction of 
change, both studies indicate that similar oxidative stress responses occur both in the 
periphery and the brain. However, the study presented herein assessed the effect of acute 
exercise only, and thus it is possible that repeated bouts of exercise are necessary for whole 
body (brain and periphery) changes to occur. Holmay et al. (2013) observed maximal changes 
in brain GSH levels after around 30 minutes delay relative to the redox change seen in blood 
in response to intravenous infusion of N-acetylcysteine. They observed a rapid decrease in 
blood GSH levels, while the brain GSH levels remained elevated until the end of 
measurement at 2 hours from infusion suggesting different environment/mechanism in the 
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brain and the blood. It is accepted that the contribution from the vasculature to the GSH levels 
measured in the brain using the MRS method is negligible (Holmay et al., 2013, Terpstra et 
al., 2011).    
4.5.4 Strengths and limitations of the study 
This study included a novel approach in assessing redox change in the brain in response to an 
acute exercise bout using MRS methodology and is also the first to investigate the effect of 
exercise on a marker of oxidative stress in the brain. However, the small sample size of the 
study and the limited sensitivity of MRS method means that the results should be interpreted 
with caution. Another strength of this study was that CBF was assessed during the exercise 
trials which may provide more insight into mechanism potentially relating to the exercise-
induced response seen in the brain and the periphery.  
4.6 CONCLUSION 
The results presented herein suggest that an acute bout of exercise can induce a change in 
brain GSH. If the mechanisms of adaptation are the same in the brain as they are in other 
tissues, then such response may contribute to brain health.  However, due to the small sample 
size and the limitation of the MRS method, this data should be evaluated with caution. 
Additional studies are required, using this methodology with larger numbers of participants, 
to assess the effect of exercise on brain GSH. A bout of HII exercise consisting of short 
phases of a very high intensity exercise elicited a greater oxidative stress in the periphery 








5 CHAPTER 5: The effect of a bespoke home based physical 
activity intervention on markers of oxidative stress and 




Home-based unsupervised exercise training has been shown to improve health in older adults. 
Assessing adherence, especially using a self-report format, in an unsupervised exercise 
intervention is problematic. The aim of the study was to assess the effect of an unsupervised 
home-based exercise intervention in community dwelling sedentary older adults. Markers of 
oxidative stress and measures of health were assessed, including cerebral hemodynamics and 
cognitive function. Physical activity was measured continuously using Basis Peak, an activity 
monitoring device. A secondary aim of the study was to test the appropriateness of the Basis 
Peak as a tool to assess physical activity in this population. The intervention failed to increase 
the level of physical activity in all the participants. No significant changes were observed in 
markers of oxidative stress or other measures of health in response to the exercise 
intervention.  Progressive goals, based on adherence measurement, are potentially important 
for the success of an unsupervised exercise intervention. Basis Peak may not be the optimal 




Ageing is associated with cognitive decline (Deary et al., 2009), diminished cerebral 
haemodynamics (Demirkaya et al., 2008, Krejza et al., 1999) and reduced physical function 
(Kuh, 2007). Physical activity has been shown to improve cognitive function in older adults 
who are healthy, with cognitive impairments and also those with diseases/conditions 
associated with ageing such as dementia (Brown et al., 2013, Heyn et al., 2004, Kramer and 
Erickson, 2007). Physical activity can improve quality of life (Conn et al., 2009, Netz et al., 
2005, Rejeski and Mihalko, 2001) and increase physical function (Chin et al., 2008, Gine-
Garriga et al., 2014) in older adults. Global cerebral blood flow (CBF) declines gradually with 
ageing (Demirkaya et al., 2008, Grolimund and Seiler, 1988, Krejza et al., 1999), whereas 
CBF has been shown to be elevated with higher aerobic fitness across the adult lifespan 
(Ainslie et al., 2008, Bailey et al., 2013). The potential mechanisms behind this increased 
CBF may be increased grey matter volumes (Colcombe et al., 2006) and more endothelium-
dependent vasodilation (Green et al., 2004).  
 The current recommended physical activity level for adults is a minimum of 150 min/week of 
moderate-intensity exercise (equivalent to approximately 1000 kcal/week) (Haskell et al., 
2007). The guidelines by the Public Health England on physical activity for older adults are: 
i) Those who participate in any amount of physical activity gain some health benefits. 
Guidelines go on to clarify that some physical activity is better than none, and more physical 
activity provides greater health benefits. ii) Physical activity should add up to at least 150 
min/week of moderate-intensity activity. iii) Those who are already regularly active at 
moderate-intensity, comparable benefits can be achieved through 75 min/week of vigorous-
intensity activity or a combination of moderate and vigorous activity. iv) Those who are at 
risk of falls should incorporate physical activity to improve balance and coordination on at 
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least two days a week (Public Health England, 2014). A volume of exercise that is about half 
of 1000 kcal/week may be sufficient, particularly for people who are frail and elderly 
(Warburton et al., 2006). A recent cohort study found that 90 min/week of moderate intensity 
exercise is effective in reducing mortality and extending life expectancy (Wen et al., 2011). 
Similarly, Takahashi et al. (2013) showed that 100 min/week walking exercise intervention in 
older adults had a protective role against oxidative stress including increased antioxidant 
potential.  
For older adults living in the community, being more physically active has the potential to 
extend home-dwelling and delay moving into a care home or hospital. Most of the exercise 
intervention studies in older adults are undertaken in supervised form usually in structured 
group sessions, and are undertaken at facilities. Only few studies have investigated 
unsupervised home-based exercise intervention under free-living conditions, and the 
assessment of adherence to the prescribed exercise in these studies are through self-report 
measures, which have limitations such as subjective bias and being reliant on memory. The 
increasing development of physical activity monitoring devices such as heart rate monitors, 
accelerometers and pedometers allows physical activity in free-living conditions to be 
objectively measured with greater confidence (Colley et al., 2008). 
The aim of this study was to assess the effect of increasing physical activity by 10 % (based 
on energy expenditure) in older adults receiving care in a bespoke home-based exercise 
intervention. Markers of oxidative stress as well other measures of health including physical 
function, cognition, cerebral haemodynamics, and quality of life were assessed. A secondary 
aim of the study was to test the appropriateness of the Basis Peak (a commercially available 





5.3.1 Study design 
A physical activity intervention tailored to each participant was developed aiming to increase 
their current physical activity level by 10 % over a period of 4-6 weeks, based on weekly 
energy expenditure. A schematic diagram of the study design and the measures assessed is 
outlined in Figure 5-1. Ethical approval for the study was obtained from the NRES 
Committee Nottingham1.  
5.3.2 Participants 
Participants (60 years and above) were all older adults receiving care in their own homes by a 
care provider, Care Companions Ltd, located in Sutton Coldfield, UK.  Clients of Care 
Companions were given participant information by the carer and asked if they were interested 
in taking part in this study. Those that expressed an interest were visited by the researcher, 
and if appropriate, were recruited for the study. All participants provided written consent 
before taking part. Four people with dementia (PWD) and four people without dementia were 
recruited. Presence of dementia was self-reported in the general health questionnaire as well 
as through the participant’s carers. 
5.3.3 Assessment of physical activity  
5.3.3.1 Comparison and selection of activity monitoring systems  
In December 2014 the following activity monitoring devices were available, and capable of 
monitoring physical activity in a form that would be acceptable to this participant group: 
Basis Peak (Basis, 2015 [online]) (BASIS an Intel Company, San Francisco, USA), Fitbit 
Flex (Fitbit Inc., San Francisco, USA), Jawbone Up (Jawbone, San Francisco, USA), Mio 





Figure 5-1 A schematic diagram of the study protocol 
1. Sign consent form
2. Complete health questionnaire
3. Cognitive function assessment- MMSE
VISIT 1
1. Cerebral haemodynamics assessment 
2. Height and weight
VISIT 2
5. Quality of life questionnaire 
3. Timed up and go test
4. Blood sample
1. Blood sample
2. Cerebral haemodynamics assessment
4. Cognitive function assessment- MMSE
VISIT 3
3. Timed up and go test
6. Physical activity questionnaire
5. Quality of life questionnaire










(Nike Inc., Oregon, USA), Polar FT60 (Polar Electro, Kempele, Finland), and Withings Pulse 
Ox (Withings, Issy-les-Moulineaux, France).  Of these devices, the Basis peak, Fitbit flex and 
the Withings pulse ox were tested by the research team. The Basis Peak, became available 
commercially in the UK in January 2015, and was selected for the study. More information on 
the selection of the device for the study is presented in section 5.4.4. 
5.3.3.2 Measurement of physical activity 
Physical activity was measured objectively using Basis Peak. This device, which is in a wrist 
watch format, measures accelerometry, heart rate, skin temperature, and electrodermal 
activity (as indicator of perspiration). Participants were asked to wear this water resistant 
activity monitor on the wrist, and to keep it on all the time including when sleeping at night. 
Participants and carers (if applicable) were instructed to charge the activity monitor every 
three days (the Basis Peak activity watch has a battery life of between 3-5 days depending on 
usage). The activity monitor is designed to synchronise data with an iPhone (iOS) or Android 
smartphone via a wireless Bluetooth connection using Basis app which communicates via the 
internet with the database held by Basis. Data from the activity monitors were synced by the 
researcher every two weeks on average. Separate user accounts were created for the different 
watches and were updated with respective participant’s age, height and weight.  
Physical activity was also assessed at the end of the exercise intervention using modified 
version of ‘Physical Activity Scale for the Elderly (PASE)’ questionnaire (appendix I). The 
main modifications to the questionnaire were as follows. i) The original PASE questionnaire 
was modified in language, away from US English to UK English, and examples were 
modified so that they were more relevant to the UK population. ii) Instead of having 
individual questions for varying intensities/forms of recreational/sports activities, in the 
modified version the participant was asked to list all recreational/sports activities. iii) An 
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additional question was added to ask if the participants had stairs in their house, and if so, 
how often they used them. The scoring method of the original PASE was used for scoring this 
modified version. 
5.3.3.3 Basis Peak data analysis 
The raw sensor data from Basis Peak activity monitor are provided in minute-to-minute 
format in CSV (Comma-Separated Value) form. This data was analysed using MATLAB 8.5 
and Statistics and Machine Learning Toolbox 10.0, The MathWorks, Inc., Natick, 
Massachusetts, United States. 
5.3.4 Physical activity intervention 
Instructions to increase an individuals’ physical activity level were provided according to the 
participant’s habitual physical activity (using the Basis peak) and his/her physical capability. 
Every effort was made to adapt the exercise training to integrate it with the lifestyle of the 
participant. Opportunities to increase the physical activity of the participants were identified 
following discussions with the participants and family members/carers. For instance, if a 
participant already walked regularly, he/she was advised to gradually increase the distance 
and pace of their current level. Participant who used to do gardening were encouraged to do 
more gardening activities. Participants without mobility problems and who had stairs in their 
house were asked to climb up the stairs an additional 5 times in their daily routine. Chair 
based exercises were undertaken in a supervised session on the first occasion (with the 
participant and the carer together). The carers and participants were asked to integrate the 
chair based exercises into their daily routine, for example they were advised to do them in the 
morning after they woke up and in the evening before going to bed so that this exercise would 
become part of their daily routine. Written instructions with figures were provided for the 












exercise is presented in Appendix II. This type of exercise was especially encouraged in 
participants with mobility issues.  
Participants were seen every 2 weeks during the study to discuss progress and to receive 
encouragement. During these visits, discussions would be carried out with the participants and 
the carer regarding the activities that they have been doing to increase their physical activity 
level and their frequencies. Participants would be acknowledged for their efforts and be 
encouraged to increase their activities further. 
5.3.5 Markers of oxidative stress in blood 
Blood samples were obtained from the antecubital vein using venepuncture. Blood samples (6 
ml) were collected in EDTA vacutainers. The blood was immediately centrifuged in a 
portable centrifuge for 15 minutes. This was immediately followed by separation of plasma 
samples which were then aliquoted and placed on ice (around 3 hours) before being stored at -
70° C. Markers of oxidative stress in plasma (malondialdehyde (MDA) levels, total 
antioxidant capacity levels and protein carbonyl) were assessed as described in chapter 2. 
5.3.6 Cerebrovascular measures 
Five participants were assessed for cerebrovascular measures before and after the exercise 
intervention. Three participants were not assessed due to participant availability. CBF velocity 
was measured from the middle cerebral artery (MCA) using TCD as described in chapter 2 
2.3. Blood pressure (BP) data was collected simultaneously using Portapres (Finapres 
Medical Systems, Netherlands), allowing acquisition of synchronised data of beat-to-beat 
variability in BP and MCAv (MCA velocity). BP was measured in the finger by 
photoplethysmography (Finapres, Netherlands). The hand with the Portapres cuff was held 
steadily in place at heart level. Both MCAv and BP were acquired continuously using an 
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analog-to-digital converter (Powerlab; AD Instruments) interfaced with a computer, and were 
subsequently analysed using commercially available software (Lab Chart, AD Instruments). 
To enhance the magnitude of alterations in BP and CBF, and to mimic such changes in daily 
life associated with changes in body posture, changes in BP and CBF were induced by sit-to-
stand manoeuvre. Participants were instructed to sit for 5 minutes and then stand for 2 
minutes which was repeated twice. BP and CBF were further monitored for 3 minutes at the 
end of the second stand. Physical assistance during standing up was provided to aid the 
performance of these manoeuvres as well as verbal instructions. 
Resting MCAv was calculated from 60 s data, one minute prior to the first stand manoeuvre. 
To evaluate the CBF response to acute posture change in the single sit-stand protocol, the 
differences between the sitting value (averaged over a period of 20 s) and the value at the 
nadir of BP (average of 5 values surrounding the nadir) for each sit-to-stand manoeuvre was 
calculated. 
5.3.7 Other outcome measures: cognition, quality of life, and physical function 
Cognitive function was assessed using the Mini Mental State Examination (MMSE) (Folstein 
et al., 1975), which takes approximately 10 minutes to administer. Quality of life was 
assessed using Dementia Quality of Life measure (DEMQoL) questionnaire (Smith et al., 
2007). Physical function was assessed using the ‘timed up and go’ test (TUG) (Podsiadlo and 
Richardson, 1991), which is a widely used clinical performance-based measure of lower 
extremity function, mobility and fall risk. For the TUG, subjects are asked to stand from a 
standard chair, walk a distance of 3 meter at a comfortable pace, turn, walk back and sit down. 
The time to complete the task was measured. At the end of the intervention, participants’ 
attitude towards taking part in the study were evaluated using an End of Study questionnaire.  
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5.3.8 Statistical analysis 
Statistical significance was accepted at the p<0.05 level. Data were analysed using SPSS 
statistical package for Windows (SPSS Inc, USA). Paired sample t-test was used to test 
differences between baseline and intervention period, while independent t-test was used to test 
for differences between PWD and the non-dementia group. Relationships were determined 
using Pearson Product Moment Correlations. Data, that was not-normally distributed, was 
either transformed for normal distribution, or an equivalent non-parametric test was carried 
out. Data are presented as means ± standard deviation of the mean (SD), unless otherwise 
stated. 
5.4 RESULTS 
5.4.1 Declaration of ownership 
In this chapter, comparison and selection of activity monitoring system was undertaken in 
collaboration with Dr Tim Collins and Dr Sandra Woolley, Lecturers in health technology, 
School of Electrical and electronic engineering, University of Birmingham. The expertise and 
advice of Dr Tim Collins was sought for the analysis of the activity monitor data. The author 
was responsible for running of the study and all further data analysis. 
5.4.2 Declaration of competing interests 
No financial support was received from Basis an Intel Company for the purpose of this study. 
5.4.3 Participants 
Participant characteristics are presented in Table 5-1. There was no significant difference in 
the age (t (6) = 1.56, p = 0.17), BMI (body mass index) (t (6) = 2.21, p = 0.07) and mean heart 
rate measured (t (6) = 0.03, p = 0.07) between PWD and the non-demented group. There was 











(n = 8) 
PWD 
(n = 4) 
Non-demented 
(n = 4) 
Age (years) 78 ± 8 82 ± 4 74 ± 9 
Height (cm) 160 ± 10 163 ± 8 158 ± 12 
Weight (kg) 72 ± 18 85 ± 11 60 ± 16 
BMI (kg/m2) 28 ± 7 32 ± 7 24 ± 4 
Mean HR measured 76.1 ± 5.5 72.8 ± 4.5 79.5 ± 4.4 
Gender ratio (m/f) 4/4 2/2 2/2 
 
Mean HR measured- mean heart rate measured by the Basis Peak activity monitor from all the 








5.4.4 Comparison and selection of activity monitoring system 
Out of the seven activity monitoring systems (Basis Peak, Fitbit Flex, Jawbone Up, Mio 
Alpha, Nike+ Fuelband SE, Polar FT60, and Withings Pulse Ox) assessed (summarised in 
Table 5-2 ), all were of wrist watch formats with the exception of Withings Pulse Ox which 
could optionally be clipped on to clothing including belt or pocket. 
First, activity monitors that did not measure heart rate were eliminated. The Withings Pulse 
Ox could measure heart rate but not continually; in order to measure heart rate it was required 
for the wearer to remove the device from the wrist strap or clip and put their finger over an 
optical sensor on the back. Furthermore, the device required the wearer to turn on and off the 
setting for sleep tracking. Thus the Withings was eliminated. The Mio Alpha was dismissed 
as it did not measure activity monitoring data apart from heart rate. The Polar FT60 required a 
separate heart rate sensor mounted on a chest strap, so was eliminated. The device that met 
criteria of measuring activity data as well as heart rate was the Basis Peak. 
5.4.5 Change in physical activity 
5.4.5.1 Analysis of activity data from Basis Peak 
Wear time of the watch was estimated as the time the activity monitor recorded heart rate, as 
the activity monitor automatically records heart rate when it is in contact with skin. The 
minimum wear time for each day was set at 75 % which amounts to 18 hours a day, with the 
exception of one participant whose minimum wear time was set at 50 % (which amounts to 12 
hours). This participant had low wear time (data shown in Figure 5-5) and the participant’s 
carer stated that the participant would often take off the watch and forget to put it back on. 







Table 5-2 Comparison of monitoring systems 
Device 







Basis - Peak Yes Yes Yes 
Fitbit - Flex Yes No Yes 
Jawbone - Up24 Yes No No** 
Mio - Alpha No Yes Yes 
Nike -  Fuelband Yes No No** 
Polar – FT60 Yes Yes* Yes 
Withings – Pulse Ox Yes Yes Yes 
 
*Requires separate chest-strap sensor for heart rate measurement  








Table 5-3 Assessment of physical activity  
 
All participants (n = 8) PWD (n = 4) 
 
Non-demented (n = 4) 
  
 
Baseline Intervention p value Baseline Intervention p value Baseline Intervention p value p value a 
Total calories 
(kcal) per day 2296 ± 344 2388 ± 367 0.37 2206 ± 287 2292 ± 107 0.44 2387 ± 413 2483 ± 527 0.63 0.50 
Steps per day 2355 ± 2478 2291 ± 2478 1.00 366 ± 342 433 ± 315 0.07 4343 ± 1902 4148 ± 2242 0.61 0.01* 
% HR > 100 
per day (bpm) 8.1 ± 8.1 7.6 ± 8.3 0.26 3.9 ± 3.0 2.5 ± 1.5 0.19 12.4 ± 9.9 12.8 ± 9.4 0.70 0.15 
% HR > mean 
HR plus 10% 
mean HR 
(bpm) 
21.8  ± 6.9 23.5  ± 7.2 0.14 18.9  ± 6.6 19.4  ± 6.6 0.65 24.6  ± 6.8 27.5  ± 5.8 0.19 0.28 
Number of 
days 8 ± 3 29 ± 8  
9 ± 3 36 ± 10 
 
6 ± 4 31 ± 7 
  
p value- comparison between baseline and intervention period (paired t-test) 
p value a- comparison between PWD and non-demented participants at baseline (independent t-test). 
* significant difference between PWD and non-demented participants at baseline 




(which were within the cut off wear time) were used for analysis for change in physical 
activity. 
5.4.5.2 Activity data from Basis Peak 
 The Table 5-3 shows various measures that were used to assess the physical activity by 
changes between the baseline and the intervention period. There was no significant difference 
in any of these measures (average calorie per day, total calorie per day, steps per day, % of the 
day heart rate was above 100 bpm, and % of the day heart rate was above mean plus 10 % of 
the mean heart rate) between the baseline and intervention period in the non-demented group, 
PWD group, or all participants as a whole. However, the increase in steps/day post-
intervention for the PWD group approached significance (p = 0.07).  
The colour scale figures in Figure 5-3 and Figure 5-4 shows activity details (calorie/minute, 
steps, and heart rate) of PWD and a non-demented participant respectively (the colour scales 
for both the participants are of the same scales). Visually it is quite clear how the non-
demented participant shown in Figure 5-4 is more active than the PWD in Figure 5-3. 
5.4.5.2.1 Assessment of activity data from Basis Peak for the aimed 10 % increase 
The measures recorded by Basis Peak to assess physical activity were evaluated for success of 
increasing physical by 10 % above the baseline period. This data is presented in Table 5-4. 
Three participants’ activity increased up to or above the 10 % aimed increase based upon 
calorie measure, three participants based upon step count, and four based upon heart rate 
measure (% of the day heart rate was above mean plus 10 % of the mean heart rate). 
However, these measures identified different participants. For example, 2 out of the 3 
participants that increased calorie count were not those which were identified as having 




Figure 5-3  Activity measurements of a PWD participant 
Left figures: calorie/minute (0-8), middle figures: steps (0-100), and right figure: heart rate/pulse (0-160) with its colour scale next to the figure. 




Figure 5-4 Activity measurements of a non-demented participant. 
Left figures: calorie/minute (0-8), middle figures: steps (0-100), and right figure: heart rate/pulse (0-160) with its colour scale next to the figure. 





Table 5-4 Aimed 10 % increase in activity 
Calorie Steps 
% HR > mean HR plus 
















1874 2061 2142 879 967 903 19.53 21.49 20.28 
2419 2660 2341 182 200 272 27.78 30.56 27.23 
2472 2719 2387 216 237 234 16.09 17.70 18.92 
2059 2264 2299 188 206 324 12.37 13.61 11.13 
2345 2580 2990 6806 7487 6472 16.10 17.71 22.98 
1928 2120 1859 3112 3423 2418 26.78 29.46 25.27 
2341 2576 2243 2608 2868 2047 32.29 35.52 35.96 
2933 3226 2843 4847 5331 5656 23.18 25.49 25.96 
 
Each row represents measures for a particular participant. The top four rows (in italics) are 
participants in PWD group and the bottom four in the non-demented group.  
Measures that were raised up to or above the 10 % aimed increase during the intervention 
period are highlighted in grey and in bold font. 






Figure 5-5 Activity measurements of the participant with the lowest activity monitor wear time. 
Left figures: calorie/minute (0-8), middle figures: steps (0-100), and right figure: heart rate/pulse (0-160) with its colour scale next to the figure. 
Top and the bottom figures showing the baseline and intervention period respectively. Each data point corresponds to average 3 minutes data. 
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5.4.5.3 Basis Peak activity monitor retention  
The mean wear time of all the participants (n = 8) was 81 ± 14 %. The wear time for the PWD 
group (n = 4) and the non-demented group (n = 4) were 73 ± 15 % and 89 ± 7 % respectively. 
There was no significant difference in the wear time between the PWD and the non-demented 
group t (6) = -2.01, p = 0.09. The lowest wear time was 57 % for a PWD participant, shown in 
Figure 5-5. 
5.4.5.4 Measurement using physical activity questionnaire 
The mean physical activity questionnaire scores for the PWD and non-demented groups were 
18 ± 20 and 107 ± 59 respectively, and this was significantly different t (6) = -2.83, p = 0.03. 
The relationship between the scores from the physical activity questionnaires (taken post 
intervention) and the data from the basis peak was assessed. Pearson correlation showed a 
significant positive correlation between the physical activity questionnaire score and the steps 
during the intervention period (lg10 transformed for normal distribution) measured by the 
activity monitor (r = 0.88, n = 8, p < 0.01) (Figure 5-6). The questionnaire scores were not 
correlated with calorie (p = 0.08), % of the day heart rate was above 100 bpm (p = 0.20), or % 
of the day heart rate was above mean plus 10% of the mean heart rate (p = 0.57). 
5.4.6 Markers of oxidative stress in blood 
Markers of oxidative stress in plasma before and after the exercise intervention are shown in 
Figure 5-7. There were no significant changes in any of the markers before and after the 
intervention: MDA levels [t (5) = 0.05, p = 0.66], total antioxidant capacity levels [t (5) = -
0.45, p = 0.67], and protein carbonyls [ Z = -0.67, p = 0.50]. 
5.4.7 Cerebrovascular measures 
There was no significant change in sitting MCAv mean following the exercise intervention (n 




































Figure 5-7 Markers of oxidative stress 
A) MDA levels, B) total antioxidant capacity, and C) protein 
carbonyl in plasma at baseline and after intervention (p = 0.66, p = 
0.75and p = 0.50 respectively). The dotted lines (green - non-
demented individual, brown – PWD participant) represent an 
individual participant, and the black solid line represents the mean of 






































































participants assessed for cerebrovascular measures during the sit-to-stand manoeuvre, 
clean/good cerebrovascular resistance (CVR) [mean arterial pressure/blood flow velocity (mm 
Hg/ cm s-1)] data was obtained from only two participants for both the pre and post 
intervention (due to loss of BP signal during the sit-to-stand manoeuvre, especially in 
participants with mobility issues).  Therefore, changes in CVR before and after the 
intervention could not be assessed statistically in this study. The data for the cerebral blood 
flow response to the manoeuvre is presented in Figure 5-8. The time series of arterial pressure 
and blood flow velocity is shown in Figure 5-9. 
5.4.8 Other outcome measures: cognition, quality of life, and physical function  
Table 5-5 shows measures of cognition, quality of life, and physical function as measured by 
MMSE, DEMQoL and TUG respectively before and after the exercise intervention. There 
was a non-significant improvement in MMSE and TUG after the exercise intervention in all 
the groups. Similarly, there was no significant change in DEMQoL. There were no significant 
differences in the MMSE and DEMQoL scores between the PWD and non-demented group at 
baseline. TUG was significantly better in non-demented group compared to PWD group at 
baseline. One participant in the non-demented group did not take part in the MMSE test, as 
the participant’s first language was not English.  
5.4.9 Participant’s perspective (End of study questionnaire) 
Five (PWD/non-demented group = 2/3) out of the eight participants thought that they had 
managed to increase their physical activity to the 10 % during the intervention period when 
asked in the end of study questionnaire (according to energy expenditure data from Basis 
Peak, only 3 participants had achieved the 10 % increase). The participants responded that 








Figure 5-8 Cerebral blood flow response to single step change in blood pressure 
Cerebral blood flow-velocity (MCAv) changes (top) and CVR index (bottom) induced by sit-
to-stand manoeuvre (n=4). Left (black lines) and right side (grey lines) are pre- and post- 












































Figure 5-9 Time series of cerebral blood flow response to single step change in blood 
pressure 
Time series of arterial pressure (AP) and MCAv before and after posture change (stand from 






Table 5-5 Other outcome measures: cognition, quality of life, and physical function 
 All participants (n = 8) PWD (n = 4) Non-demented (n = 4)  
 Baseline Intervention p value Baseline Intervention p value Baseline Intervention p value p value a 
MMSE* 25.6 ± 4.2 26.1 ± 4.6 0.48 24.3  ± 5.1 24.5  ± 5.6 0.86 27.3 ± 2.5 28.3  ± 2.1 0.22 0.38 
DEMQoL 95.5 ± 10.0 98.4 ± 10.8 0.57 94.5 ± 8.9 90.5 ± 9.5 0.37 96.5 ± 12.4 106.3 ± 3.9 0.30 0.80 
TUG 21.1 ± 14.3 19.3 ± 14.4 0.14 31.1 ± 13.7 29.1 ± 14.8 0.43 11.1 ± 4.7 9.6 ±3.8 0.06 0.03 ϕ 
p value- comparison between baseline and intervention period (paired t-test) 
p value a- comparison between PWD and non-demented participants at baseline (independent t-test).  
ϕ - significant difference between PWD and non-demented participants at baseline 
* - MMSE only had 3 participants in the non-demented group and thus there were only 7 participants overall  




participants responded that the activity monitor was easy and comfortable to wear, with the 
exception of one participant who found it uncomfortable at night. This participant commented 
“it was ok during the day, but was difficult sleeping with it during the night”. 
5.5 DISCUSSION 
The exercise intervention was not successful in increasing the physical activity (assessed by 
energy expenditure) of all of the participants. As would be potentially expected when 
considering this failure to achieve the desired increase in physical activity level, no significant 
changes were observed in measures of oxidative stress, nor other measures of health including 
CBF, quality of life, cognition, and physical function. The findings from the study suggest the 
delivery of the physical activity intervention was not successful. The Basis Peak identified 
different participants as having achieved a 10 % increase in physical activity dependent on 
which outcome was used to measure physical activity.  
The unsupervised home-based exercise training design in this study was not successful in 
increasing the physical activity of all participants, however previous studies have shown that 
unsupervised exercise interventions can increase physical activity levels (Hillsdon et al., 
1995).  Numerous studies, including randomised controlled trails, have found home-based 
exercise training to be effective in improving the respective study measures (such as balance 
and physical function) (Ashburn et al., 2007, Campbell et al., 1999, Donat and Ozcan, 2007, 
Gardner et al., 2011, Jette et al., 1996, Li et al., 2015, Marshall et al., 2001, Mock et al., 2001, 
Moorcroft et al., 2004, Olney et al., 2006, Schwartz, 2000, Segal et al., 2001, van Diest et al., 
2016). In addition, unsupervised exercise training has been successful in older adults both 
living both in the community (Campbell et al., 1999, Jette et al., 1996, Li et al., 2015, van 
Diest et al., 2016) and nursing homes (Donat and Ozcan, 2007). 
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Unsupervised home-based exercise training has several advantages to supervised exercise 
training. Compared to supervised exercise training, unsupervised exercised training is cost 
effective and not labour intensive. More importantly, participants may adapt better to 
unsupervised home exercise sessions rather than to supervised sessions in a lab or facility 
based environment. This was an important consideration for the participants of the current 
study, as they were home based and received care visits at home. Although participants were 
free-living, and independent in their own homes, they did not often leave the house, and 
almost never alone, thus exercise that could be undertaken in the home, or walking close to 
home with their carer or family member was important. Facility based group exercise 
interventions may impact adherence due to time constrains and barriers in getting to the 
facility. Some studies have found supervised exercise training to be superior to unsupervised 
home-based training (Donat and Ozcan, 2007, Olney et al., 2006), whereas, other studies have 
found that unsupervised home based exercise intervention resulted in larger improvement in 
physical functioning compared to supervised facility based training (Gardner et al., 2011, 
Segal et al., 2001). Nevertheless, transferring an exercise training programme to the 
community and sustaining it, is a challenge that needs to be met, whether that programme be 
supervised or unsupervised.  
A review looking at studies of physical activity promotion, found that unsupervised exercise 
interventions are most effective with personalised instructions, continued support/contact, 
exercise of a moderate intensity, not dependent on attendance at a facility, and an exercise 
programme that can easily fit into an existing lifestyle (Hillsdon et al., 1995). The study 
design of the current study met these recommendations. However, there are several potential 
factors that may have contributed to the failure of the current intervention in achieving the 
aimed increase in physical activity. Although the researcher was in contact with the 
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participants during the intervention period to check on the study progress and to motivate the 
participants, the data on physical activity undertaken was not analysed until the end of study, 
which meant that progress goals were not based on objective measures taken from the activity 
monitor. Adherence facilitation is important; a study (Duncan and Pozehl, 2002) looking at 
adherence to unsupervised exercise following completion of a supervised exercise programme 
found that exercise adherence was higher in those who received adherence facilitation 
compared to control group who did not receive facilitation (facilitation involved graphic 
depiction of each patient’s exercise goals in comparison to each patients’ exercise 
participation).  Although the current study was undertaken in collaboration with a care 
provider, the limited time that the carers spent with some of the participants (for example 
some participants received regular and multiple short visits daily) may not have been adequate 
to facilitate the integration of regular exercise into their daily routine.  
Basis peak (with its ability to monitor heart rate continually) was the most suitable activity 
monitor to meet the requirements of the study, at the time of assessment of potential activity 
monitors for this study. Ability to measure heart rate continually was a priority for selection 
of the activity monitor to be used. This was because the population group of our study were 
expected to be sedentary with some mobility issues, so monitoring heart rate would allow 
alternative measure of physical activity to the step count measure.  Motion sensors such as 
accelerometers and pedometers are mainly limited to ambulatory activities (Crouter et al., 
2004). Although the use of heart rate for estimating energy expenditure during exercise has 
limitations: i.e. factors such as stress, hydration level, gender, temperature and humidity can 
effect heart rate (Crouter et al., 2004), it is considered to be a valid measure to quantify 
exercise energy expenditure (Colley et al., 2008, Hiilloskorpi et al., 2003). Heart rate is 
linearly related to oxygen uptake for dynamic activities involving large muscle groups, so it 
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can provide a reasonable estimate of energy expenditure during exercise, and could be 
valuable tool for quantifying intensity of exercise bouts  (Crouter et al., 2004).  
Basis Peak, as a tool to assess physical activity in older adults, had both its pros and cons. The 
step count measured by the Basis Peak was positively correlated to the physical activity 
questionnaire score, which suggests that the activity monitor has the capability to accurately 
assess step count in this population. The wrist watch format (and displaying time) of the Basis 
Peak activity monitor is a familiar format for participants who are not accustomed to activity 
monitoring compared to activity monitors with other wear locations such as waist, ankle or 
thigh. Additionally, it is waterproof, which enables wearers to keep the device on at all times 
including when showering, thus minimising the chances of participants forgetting to put the 
device back on. This is perhaps particularly beneficial for participants with memory problems. 
This is supported by the high wear time in this study; 81 % of the total time on average in all 
participants and 73 % of the total time in the PWD group. One of the main drawbacks of the 
Basis Peak activity monitor is its short battery life. If it ran out of battery, it had to be synced 
with its app in order to sync the time on the activity monitor. Data, from the period when time 
on the activity monitor was not synced, cannot be acquired as Basis Peak produces data in 
relation to time. Assessing measures obtained from Basis Peak to check if participants were 
successful in meeting the aimed 10 % increase in physical activity level showed that different 
measures identified different participants to have achieved the 10 % increase (3 participants 
increased energy expenditure over 10 % during the intervention period).  Thus this monitor 
may not be appropriate for people who are very sedentary. Additionally, acquiring activity 
measures with it for periods longer than couple of days (as in this study) would require 
monitoring that the battery is charged regularly. Additionally, the memory capacity of the 
activity monitor was only around two weeks (depending on usage). 
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There was no significant improvement in any of the blood biomarkers of oxidative stress, or 
markers of health measured in the study presented herein. Previous studies, in healthy older 
adults as well as PWD, have shown that exercise intervention training can improve measures 
of oxidative stress (Takahashi et al., 2013), as well as the measures of quality of life (Liu-
Ambrose et al., 2005, Williams and Tappen, 2008), cognition (Colcombe and Kramer, 2003, 
Kemoun et al., 2010, Lautenschlager et al., 2008), and physical function (Kalapotharakos et 
al., 2010, Kemoun et al., 2010, Rolland et al., 2007). However, as this study was not 
successful in achieving the aimed increase in physical activity level, it is not surprising that no 
significant improvements were seen in these measures after the exercise intervention. 
Similarly, no changes in CBF were observed following the exercise intervention. Despite 
higher aerobic fitness being linked to higher CBF across the adult lifespan (Ainslie et al., 
2008, Bailey et al., 2013), human studies have not found exercise training to increase CBF  in 
young and old individuals (Murrell et al., 2013, Tomoto et al., 2015) or in stroke patients 
(Ivey et al., 2011). We could not assess cerebral autoregulation statistically due to problems 
acquiring clean BP data from our small sample size. Some of the participants had mobility 
issues which affected the BP signal during standing and during sit and stand manoeuvres.  
The level of physical activity of the PWD group was significantly lower compared to the non-
demented group, both when assessed by the physical activity questionnaire and the step count 
measured by the Basis Peak. The PWD group also had impaired performance in physical 
function, assessed by TUG, compared to the non-demented group. In our small sample sized 
study, due to problems in acquiring samples and measurements from all participants, it was 
not appropriate to run statistical tests on markers of oxidative stress and CBF to compare 
between the PWD and the non-demented participants. 
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One of the main strengths of the study presented herein was in the measurement of physical 
activity of the participants: i) the objective measurement of physical activity and ii) 
continuous measurement of physical activity throughout the day during the baseline and 
intervention period. No previous studies were found that undertook an unsupervised exercise 
intervention measuring adherence with an activity monitor continuously through the day. 
With unsupervised exercise training, adherence is not easily monitored, and is usually done by 
self-report in form of diaries, charts or questionnaires. These subjective measures of 
adherence have the problem of overestimation (Conway et al., 2002). Whereas, the main 
limitation of the study was the small sample size, which means that the findings of the study 
should be interpreted with caution. 
5.6 CONCLUSION  
The home-based unsupervised physical activity intervention presented herein, failed to 
increase the level of physical activity, assessed by energy expenditure, in sedentary older 
adults. No changes were found in markers of oxidative stress or other health measures 
assessed in response to the exercise intervention. Progressive goals, based on adherence 
measurement, are potentially important for the success of an unsupervised exercise 
intervention. Basis Peak may not be the optimal tool for assessing physical activity in 













Brain GSH is a potential marker of redox status and MRS represents an important non-
invasive methodology to monitor its changes. In a small cohort of sedentary young men, an 
acute bout of moderate exercise caused a decrease in brain GSH. In the periphery, HII, an 
exercise involving a very high intensity, was found to elicit a greater oxidative stress response 
when compared to moderate intensity exercise in the traditionally prescribed form of 
continuous steady state. The CBF to the brain seemed to be protected against hyperperfusion 
during the high intensity phase of the HII exercise. An unsupervised exercise intervention in 
older adults was not successful in increasing the physical activity level of all the participants 
to the aimed 10 % increase, which was objectively measured using an activity monitor. There 
were no significant changes in markers of oxidative stress or other health measures in 
response to this exercise intervention. The effectiveness of objectively measuring habitual 





Optimising exercise to target the ageing brain has the potential to prevent diseases associated 
with ageing including dementia, but although the benefits of exercise for the brain are 
becoming increasingly apparent, its mechanisms are still poorly understood (Lucas et al., 
2015). There is clear evidence that exercise can play a significant role in both the prevention 
as well as treatment of diseases and conditions associated with ageing such as dementia, 
cancer and diabetes (Hamer and Chida, 2009, Heyn et al., 2004, Lee et al., 2012). With no 
curable treatment for many of these diseases at present, there is a necessity to focus on 
exercise as a modifiable risk factor, which would help reduce the ever-increasing economic 
burden associated to these conditions. 
Exercise or physical activity of any intensity is probably beneficial. However, there is not 
enough data regarding low intensity exercise to verify this (Lee and Shiroma, 2014). There is 
a need to investigate if low intensity physical activities are also capable of inducing similar 
benefits as moderate to vigorous intensity physical activities, especially in older population 
who are likely to be restricted in their physical capabilities. If indeed they are, their beneficial 
effects are probably lower compared to higher intensity activities as studies (Bailey et al., 
2004, Goto et al., 2007, Guiraud et al., 2012a, Swain and Franklin, 2006, Wang and Huang, 
2005) (including that presented in chapter 4) have shown exercise intensity to be correlated to 
the measurement assessed including oxidative stress (although chronic exercise of high 
intensity can be detrimental, an area that this thesis has not covered). What is certain is that 
the intensity of exercise contributes to the extent of the resulting exercise effect whether it be 
oxidative stress other exercise induced effects. 
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6.2 Effect of acute exercise in the brain  
The effect of acute exercise on brain GSH was investigated using an MRS method in 
sedentary young men. In chapter 3 an MRS method was optimised to detect and quantify 
GSH in the brain. Then, in chapter 4, brain GSH in response to two types of exercise, HII and 
continuous moderate exercise, were assessed using this optimised MRS method. The results 
presented suggested that brain GSH decreased in response to an acute bout of continuous 
moderate intensity exercise, an effect that was not seen with HII. If indeed an acute bout of 
exercise of moderate intensity is capable of inducing redox changes in the brain, an organ that 
is highly susceptible to oxidative stress, it is plausible that it may lead to an adaptive response 
to protect the brain against oxidative stress. This is in agreement with the findings reported in 
rodent studies that aerobic moderate exercise may promote a protective antioxidant function 
of the brain (Camiletti-Moiron et al., 2013). This is the first study to investigate the effect of 
exercise on one of the markers of oxidative stress in the human brain.  
Additionally, CBF to the brain during the two types of exercise was assessed by measuring 
MCAv using TCD, a method which is capable of yielding beat-by-beat measures of CBF. 
Looking at each of the individual responses to the exercise bouts, the change in MCAv was 
similar, however, looking specifically at the high intensity phase of HII trial showed that there 
was a significant decrease in MCAv after an initial increase. Previous studies have shown that 
CBF increases with exercise until ~60 % V̇O2max after which hyperventilation-induced 
hypocapnia reduces CBF towards resting value (Ogoh and Ainslie, 2009). Indeed, at the start 
of the high intensity phase of HII, the MCAV increased which then rapidly declined within 
seconds. This instantaneous decrease in MCAv indicates that there is a very finely tuned 
mechanism of CBF which protects the brain against hyperperfusion and thus it damaging 
consequences such as BBB disruption.   
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6.3 Effect of exercise on oxidative stress in the periphery  
In addition to brain GSH, chapter 4 investigated the effect of the two types of exercise on 
markers of oxidative stress in the blood. There was a difference in the oxidative stress 
response in the blood between the two types of exercise, with HII eliciting greater changes in 
oxidative stress markers. This was in contrast to the finding in the brain where moderate 
exercise seemed to have elicited a significant decrease in brain GSH, compared to HII. This 
suggests that the HII used in this study elicited a stronger oxidative stress in the periphery 
then moderate exercise trial. This is in agreement with various studies that have reported that 
higher intensity exercise results in greater oxidative stress compared to moderate intensity 
(Goto et al., 2007, Quindry et al., 2003, Wang and Huang, 2005). In contrast to the finding in 
chapter 4, a recent study by Wadley et al. (2016a)  reported that HII elicited a similar 
oxidative stress response compared to moderate exercise in plasma. However, Wadley et al. 
(2016a) used a comparatively lower intensity profile in the HII, to the study presented in this 
thesis, and indeed the variety of HII forms used in studies make it difficult to directly compare 
results. A schematic diagram of existing literature regarding exercise intensity and oxidative 
stress together with the findings from chapter 4 is presented in Figure 6-1. 
6.4 Unsupervised exercise intervention in older adults 
In chapter 5, a low dose unsupervised home-based exercise intervention was prescribed in a 
group of older adults. The intervention was unsuccessful in increasing the physical activity, 
assessed by energy expenditure, of all the participants to the aimed 10 % increase from their 
baseline level. Thus as would be potentially expected, the intervention did not alter markers of 







Figure 6-1 Exercise intensity and oxidative stress: existing literature plus thesis finding 
Schematic diagram showing the effect of regular and acute exercise according to exercise 
intensity. Findings from existing literature is presented along with the finding of the study 
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the exercise intervention included factors found to be effective for unsupervised exercise 
training including personalised instructions, continued support/contact, not dependent on 
attendance of a facility, and a programme that can fit into an existing lifestyle as 
recommended by Hillsdon et al. (1995), the intervention was not successful probably as it 
lacked progressive goals and adequate facilitation. 
6.5 Basis Peak as a tool to assess habitual physical activity in older adults 
A secondary aim of the study presented in chapter 5 was to assess the appropriateness of the 
activity monitor, Basis Peak, to measure habitual physical activity in older adults. Basis Peak 
was chosen from the range of available activity monitors as it was capable of measuring 
continuous heart rate along with other activity measures, whilst not being invasive or unusual 
to wear. The adherence to wearing Basis Peak was good, although Basis Peak had its 
limitations for wear, as with any other activity monitor. Basis Peak, in the form of wrist 
watch, was able to collect a wealth of information through 24 hours. 
There are certain issues to take into account while measuring physical activity in older adults 
using such activity monitors. The physical fitness and the type of activities differ between 
older and younger adults. One of the criteria for the selection of activity monitor was ability to 
measure heart rate continually. As some of the participants of this study would be expected to 
have mobility issues as well as being sedentary and this would allow alternative assessment of 
physical activity. It was found that scores from the physical activity questionnaire were 
correlated to the steps counts measured by Basis Peak, but not to other measures including 
heart rate. This may be due to limitations with the device finding heart rate if not worn tight 
enough, or may be due to the very small increases seen with low intensity activity such as arm 
raises or sit to stand movements. The device is perhaps most successful in detecting the 
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magnitude of increase seen when running or cycling is initiated. Overall, Basis Peak is able to 
provide very informative data on physical activity but with its current features it was not an 
optical activity monitor to assess physical activity in this population. 
6.6 Strengths and limitations  
There were many novel investigations carried out in the studies presented in this thesis. GSH, 
one of the markers that is generally used to assess oxidative stress, was measured for the first 
time in the brain in response to acute exercise. This was the first work to measure HII induced 
changes in CBF, even though there is an increasing interest in this form of exercise as an 
alternative to improve health. In the study in older adults, the exercise intervention in free 
living condition was measured objectively using an activity monitor –Basis Peak. The sample 
size of the studies presented is perhaps the main limitations of the studies presented.  
6.7 Future directions 
Brain is an import organ to target for exercise-induced benefits, however, it is a difficult organ 
to access. With advancement of technologies available to access various measures in the 
brain, more studies are starting to investigate the exercise-induced effects in the brain. In 
order to further validate the finding presented herein that an acute bout of moderate exercise 
can decrease brain GSH, the effect of acute exercise on brain GSH should be assessed on a 
larger sample size, especially due to the limitations in the sensitivity of MRS method with 
current technology. The findings from chapter 4 suggest that the brain might be protected 
against sudden high intensity exercise induced hyperfusion injury, at least in apparently 
healthy young adults. Exercise is not risk free, especially during very high intensity exercise. 
Previous studies including a meta-analysis review reported that HII can be safe and that risk 
of cardiovascular event with HII is low even though HII has ~5 times higher risk of acute 
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adverse cardiovascular event compared to continuous moderate exercise (Lucas et al., 2015, 
Rognmo et al., 2012, Weston et al., 2014). A next step would be to look into elderly 
population- in order to investigate if HII induced effects on measures of blood flow and 
oxidative stress in the brain are similar to that in young individuals. 
In the periphery, it is evident that higher intensity exercise induces a greater oxidative stress 
response (as observed in the study presented in chapter 4) that would potentially lead to better 
adaptive response. Older adults, especially those with mobility issues, could potentially take 
part in higher intensity exercise in a suitable format to suit their condition, in order to assess 
the exercise induced responses due to varying form of exercise intensity.   
6.8 Concluding remarks 
The work presented in this thesis has enhanced our understanding of exercise and oxidative 
stress, and physical activity in older adults with the following novel findings: 
1. Brain GSH seems to be decreased in response to acute exercise bout, but further 
investigation is required to confirm this finding. 
2. A HII bout, involving very high intensity exercise phases, elicited a greater oxidative 
stress response in blood/plasma compared to a continuous moderate exercise. 
3. During the high intensity phase of HII, there was a rapid significant decrease in the 
MCAv after the initial increase, which suggests the brain is protected against 
hyperperfusion. 
4. An activity monitor, Basis Peak, has limitations in its capability to measure physical 
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